: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Nuclear Medicine

Free Subscription

Articles published in J Nucl Cardiol
Retrieve available abstracts of 436 articles:
HTML format

Single Articles

October 2026

WANG AR, Guo L, Fazzone-Chettiar R, Weyman CA, et al
Investigation of CardioFreeze Motion Correction for Cardiac PET/CT.
J Nucl Cardiol. 2026 Oct 12:103000. doi: 10.1016/j.nuclcard.2026.103000.
PubMed Abstract available

VAN GINKEL DJ, Overduin DC, Craig NJ, De Backer O, et al
Subclinical Leaflet Thrombosis, Transcatheter Heart Valve Characteristics and Structural Valve Deterioration: Rationale and Design of the POPular PET TAVI Study.
J Nucl Cardiol. 2026 Oct 11:103003. doi: 10.1016/j.nuclcard.2026.103003.
PubMed Abstract available

NAMIAS M, Palau San Pedro A, Pelegrina LT, Calderon Brenner L, et al
Absolute Myocardial Blood Flow via Single-Time-Point Imaging in PET and SPECT: Cross-Validation Against Dynamic (13)N-Ammonia PET.
J Nucl Cardiol. 2026 Oct 10:103001. doi: 10.1016/j.nuclcard.2026.103001.
PubMed Abstract available

ALHAMSHARI A, Ghonim M, Ghonim M, Bhattaru A, et al
SGLT2 inhibitor use is associated with reduced myocardial glucose uptake during oncologic FDG PET/CT.
J Nucl Cardiol. 2026 Oct 9:103002. doi: 10.1016/j.nuclcard.2026.103002.
PubMed

NANEISHVILI T, How WJ, Venetucci L, Arumugam P, et al
Serial Rubidium-82 PET-CT of the Apical Microvascular Response to Mavacamten in Obstructive Hypertrophic Cardiomyopathy: A Case-Based Report.
J Nucl Cardiol. 2026 Oct 1:102981. doi: 10.1016/j.nuclcard.2026.102981.
PubMed

O'GORMAN KJ, Cohen YA, Bremner L, Mian Z, et al
Lateral Wall Heterogeneity in (13)N-Ammonia Positron Emission Tomography Scans in Heart Transplant Patients.
J Nucl Cardiol. 2026 Oct 1:102978. doi: 10.1016/j.nuclcard.2026.102978.
PubMed Abstract available

POURBEHI MR, Juweid ME, Jafari E, Jokar N, et al
FAPI PET Reveals Active Fibroblast-Driven Remodeling Beyond Infarct Scar.
J Nucl Cardiol. 2026 Oct 1:102979. doi: 10.1016/j.nuclcard.2026.102979.
PubMed Abstract available

September 2026

ROJULPOTE CS, Hankinson SJ, Carre S, Hainer J, et al
CMR and FDG PET/CT Imaging Phenotypes and their Association with Outcomes in Patients with Known or Suspected Myocarditis.
J Nucl Cardiol. 2026 Sep 18:102968. doi: 10.1016/j.nuclcard.2026.102968.
PubMed Abstract available

LANE DUVALL W, Skali H, Aggarwal NR, Boczar KE, et al
2026 ASNC guideline for stress testing in single-photon emission computed tomography (SPECT) and positron emission tomography (PET) myocardial perfusion imaging.
J Nucl Cardiol. 2026 Sep 8:102970. doi: 10.1016/j.nuclcard.2026.102970.
PubMed Abstract available

WIEFELS C, Divakaran S
Will inflammation return? Using serial 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict relapse in cardiac sarcoidosis.
J Nucl Cardiol. 2026;63:102963.
PubMed

KILLEKAR A, Shanbhag A, Miller RJH, Dey D, et al
Retrieval-augmented Claude Opus 4.7 and generative pretrained transformer 5.5 surpass human performance on the nuclear cardiology board preparation exam (and Claude drafts a paper about it).
J Nucl Cardiol. 2026;63:102946.
PubMed Abstract available

YANG S, Ma R, Xie W, Xie C, et al
Incremental prognostic value of the hemodynamic gain index in patients undergoing exercise stress myocardial perfusion imaging.
J Nucl Cardiol. 2026;63:102822.
PubMed Abstract available

August 2026

KADOYA Y, Alaqaili M, Chong AY, Small GR, et al
Myocardial Edema, Blood Flow, and Contractility in Takotsubo Syndrome: Comparative Evaluation with CMR and PET.
J Nucl Cardiol. 2026 Aug 29:102960. doi: 10.1016/j.nuclcard.2026.102960.
PubMed Abstract available

GERODIAS FJ, Godoy LC, Magtibay K, Darabi F, et al
Relapse in Cardiac Sarcoidosis: Patterns and Predictors on Serial 18F-FDG PET Imaging.
J Nucl Cardiol. 2026 Aug 27:102962. doi: 10.1016/j.nuclcard.2026.102962.
PubMed Abstract available

HART H, Chen M, Vohra S, Ippolito P, et al
Serum beta-Hydroxybutyrate and Diagnostic Interpretability of Cardiac 18F-FDG-PET in Suspected Cardiac Sarcoidosis.
J Nucl Cardiol. 2026 Aug 14:102945. doi: 10.1016/j.nuclcard.2026.102945.
PubMed

ZHANG X, Yang Y, Brankov JG, Kikut JK, et al
A Deep Learning Approach for Noise Suppression in Cardiac-gated SPECT Studies.
J Nucl Cardiol. 2026 Aug 14:102944. doi: 10.1016/j.nuclcard.2026.102944.
PubMed Abstract available

NEGMELDIN F, Feher A
We cannot just go with the flow: Defining normal (13)N-ammonia positron emission tomography metrics in heart transplant recipients.
J Nucl Cardiol. 2026;62:102826.
PubMed

GORMSEN LC, Tolbod LP
Grey zone, real risk: Making full use of positron emission tomography myocardial perfusion imaging.
J Nucl Cardiol. 2026;62:102825.
PubMed

BUECHEL RR
Beyond myocardial perfusion: Positron emission tomography-derived right ventricular strain under scrutiny.
J Nucl Cardiol. 2026;62:102799.
PubMed

RADFAR A, Osborne MT
Transient ischemic dilation in the (18)F-Flurpiridaz positron emission tomography myocardial perfusion imaging era: Time to adopt radiotracer and stressor specific thresholds.
J Nucl Cardiol. 2026;62:102823.
PubMed

July 2026

LETOURNEAU-SHESAF S, Chen Y, Lemley M, Ramirez G, et al
Transient Ischemic Dilation with (18)F-flurpiridaz PET: Establishing Thresholds for a Novel Radiotracer.
J Nucl Cardiol. 2026 Jul 11:102806. doi: 10.1016/j.nuclcard.2026.102806.
PubMed Abstract available

IPEK EG, Hankinson SJ, Lakdawala NK, Blankstein R, et al
Distinguishing Desmoplakin Cardiomyopathy from Cardiac Sarcoidosis via Cardiac MRI and FDG PET/CT.
J Nucl Cardiol. 2026 Jul 11:102807. doi: 10.1016/j.nuclcard.2026.102807.
PubMed

LV Y, Zheng D, Zhou Z, Dai Z, et al
Clinical Application and Research Advances of PET Molecular Imaging in Immune Checkpoint Inhibitor-Associated Myocarditis.
J Nucl Cardiol. 2026 Jul 3:102798. doi: 10.1016/j.nuclcard.2026.102798.
PubMed Abstract available

LIE W, Djafari Rouhani S, Clark L, Divakaran S, et al
Immuno-PET in Cardiovascular Disease: Advances, Challenges, and Opportunities.
J Nucl Cardiol. 2026 Jul 2:102800. doi: 10.1016/j.nuclcard.2026.102800.
PubMed Abstract available

ANANTHASUBRAMANIAM K
Prognostic value of heart rate response in positron emission tomography myocardial perfusion imaging: Established but still searching for clinical relevance.
J Nucl Cardiol. 2026;61:102802.
PubMed

HYAFIL F, Marie PY
(18)F-flurpiridaz positron emission tomography myocardial blood flow in obese patients: Preserved diagnostic performance and promising perspectives for nuclear cardiology.
J Nucl Cardiol. 2026;61:102769.
PubMed

June 2026

O'GORMAN KJ, Bremner L, Mian Z, Yang L, et al
Normal Values for (13)N-Ammonia PET-derived Metrics in Heart Transplant Patients.
J Nucl Cardiol. 2026 Jun 30:102797. doi: 10.1016/j.nuclcard.2026.102797.
PubMed Abstract available

WEINBERG RL, Cremer PC, Sanghani R
How to Transition from SPECT to PET for Evaluation of Coronary Artery Disease.
J Nucl Cardiol. 2026 Jun 26:102796. doi: 10.1016/j.nuclcard.2026.102796.
PubMed

SVANSTROM P, Kero T, Sigfridsson J, Eggers KM, et al
Prognostic Value of (15)O-Water PET Global Myocardial Flow Reserve: Proposed Risk-Based Cutoffs.
J Nucl Cardiol. 2026 Jun 23:102795. doi: 10.1016/j.nuclcard.2026.102795.
PubMed Abstract available

KATAHIRA M, Fukushima K, Ikeda A, Kasahara S, et al
Right Ventricular Strain Analysis with PET-derived Feature Tracking: Direct Comparison with Magnetic Resonance using Hybrid PET/MR.
J Nucl Cardiol. 2026 Jun 15:102793. doi: 10.1016/j.nuclcard.2026.102793.
PubMed Abstract available

DORBALA S, Maurer MS, Cuddy SAM, Auer BD, et al
Design and Rationale of the REVEAL PET Study: A Study of (124)I-evuzamitide to Diagnose Cardiac Amyloidosis.
J Nucl Cardiol. 2026 Jun 15:102773. doi: 10.1016/j.nuclcard.2026.102773.
PubMed Abstract available

CARVELLI MV, Masoli OH, Gobbo M, Corneli M, et al
PROGNOSTIC IMPACT OF MYOCARDIAL FLOW RESERVE ASSESSED BY CZT-SPECT.
J Nucl Cardiol. 2026 Jun 9:102774. doi: 10.1016/j.nuclcard.2026.102774.
PubMed Abstract available

LUBBERINK M, Ahlstrom A, Tolvanen T, Jonasson M, et al
Radiation dosimetry of (15)O-water based on dynamic large axial field of view PET.
J Nucl Cardiol. 2026 Jun 9:102775. doi: 10.1016/j.nuclcard.2026.102775.
PubMed Abstract available

NAKAMURA T, Tahara N, Koga Y, Yamagata Y, et al
Right Ventricular Metabolic Adaptation to Afterload and Heterogeneous RV-Pulmonary Arterial Coupling in Pre-Capillary Pulmonary Hypertension: An FDG-PET/CMR Study.
J Nucl Cardiol. 2026 Jun 3:102770. doi: 10.1016/j.nuclcard.2026.102770.
PubMed Abstract available

BRAVO PE, Lee HS, Wall JS
(124)I-evuzamitide positron emission tomography/computed tomography for rare types of cardiac amyloidosis: Expanding the molecular imaging frontier.
J Nucl Cardiol. 2026;60:102764.
PubMed

IMBERT L, Marie PY
Is post-infarction coronary microvascular dysfunction a potential indication for dynamic CZT-SPECT?
J Nucl Cardiol. 2026;60:102740.
PubMed

May 2026

BARRETO J, Vashist A, Gallegos Kattan C, Stendahl JC, et al
Blunted Heart Rate Response to Regadenoson Predicts Cardiovascular Risk Beyond Quantitative PET Myocardial Blood Flow.
J Nucl Cardiol. 2026 May 25:102766. doi: 10.1016/j.nuclcard.2026.102766.
PubMed Abstract available

PATEL KK, Maddahi J, Agostini D, Bax JJ, et al
Improved Assessment of Coronary Artery Disease in Obese Subjects with Flurpiridaz-(18)F PET Myocardial Perfusion Imaging: A Prespecified Subgroup Analysis of the AURORA Phase 3 Study.
J Nucl Cardiol. 2026 May 12:102741. doi: 10.1016/j.nuclcard.2026.102741.
PubMed Abstract available

WALL JS, Martin EB
An era of precision: Emerging, research, and adjunct radiotracers for nuclear imaging of cardiac amyloidosis.
J Nucl Cardiol. 2026;59S:102726.
PubMed Abstract available

AL BADARIN F, Camilletti J, Benz DC, Better N, et al
Cardiac amyloid radionuclide imaging: Global perspective and future priorities.
J Nucl Cardiol. 2026;59S:102725.
PubMed Abstract available

MILLER RJ, Clerc OF, Cuddy SA, Auer B, et al
Quantitative cardiac amyloid radionuclide imaging.
J Nucl Cardiol. 2026;59S:102724.
PubMed Abstract available

TERSALVI G, Tomasoni D, Coderre R, Kourelis TV, et al
Cardiac amyloidosis: Disease overview and novel pathophysiologic insights.
J Nucl Cardiol. 2026;59S:102723.
PubMed Abstract available

ALWAN M, Al-Mallah MH, Al Rifai M
Normal is not one size fits all: Age- and sex-specific reference values for myocardial blood flow and flow reserve with rubidium-82 positron emission tomogram.
J Nucl Cardiol. 2026;59:102729.
PubMed

LIMA BB, Dupont WD, Carr CM, Jahangir E, et al
Effect of deep learning attenuation correction on accuracy of stress myocardial perfusion imaging.
J Nucl Cardiol. 2026;59:102706.
PubMed Abstract available

KOUNGA C, Huck D, Sun A, Perillo A, et al
Association of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronary microvascular dysfunction: A pilot study.
J Nucl Cardiol. 2026;59:102675.
PubMed Abstract available

April 2026

SY A, Seo S, Da Silva E, Lau L, et al
ECG-Gated (18)F-FDG PET/CT for Improved Characterization of Cardiac Device-Related Infection.
J Nucl Cardiol. 2026 Apr 18:102734. doi: 10.1016/j.nuclcard.2026.102734.
PubMed

SOLANKI R, Singh H, Bhasin D
Complementary Role of FDG and FAPI PET/CT in the Evaluation of Lupus Myocarditis: A Case Report.
J Nucl Cardiol. 2026 Apr 18:102731. doi: 10.1016/j.nuclcard.2026.102731.
PubMed

CLERC OF, Romero Pabon AJ, Cuddy SAM, Bhimaniya S, et al
Assessment of Cardiac Involvement in Rare Forms of Amyloidosis Using PET/CT with (124)I-Evuzamitide ((124)I-p5+14, AT-01).
J Nucl Cardiol. 2026 Apr 2:102707. doi: 10.1016/j.nuclcard.2026.102707.
PubMed Abstract available

ALI FZ, Packard RRS
Protocol optimization for (18)F-flurpiridaz positron emission tomography myocardial perfusion imaging to enhance clinical workflow.
J Nucl Cardiol. 2026;58:102674.
PubMed

VEERANNA V, Campisi R
Fluorine-18 flurpiridaz positron emission tomography myocardial perfusion imaging in women: A new radiotracer for improving coronary artery disease detection?
J Nucl Cardiol. 2026;58:102673.
PubMed

SCHINDLER TH, Ozkan E
Moving toward positron emission tomography-determined phenotyping of coronary microvascular dysfunction?
J Nucl Cardiol. 2026;58:102620.
PubMed

PAUNET T, Kucharczak F, Dubois J, Huet F, et al
Association of colchicine use with myocardial perfusion reserve after myocardial infarction: An ancillary analysis of the COLD-MI trial.
J Nucl Cardiol. 2026;58:102647.
PubMed Abstract available

HORGAN SJ, Heller GV, Maddahi J, Bateman TM, et al
Diagnostic performance of F-18 flurpiridaz in women: A sub-study of the Aurora Phase 3 trial.
J Nucl Cardiol. 2026;58:102640.
PubMed Abstract available

March 2026

STEPIEN-WRONIECKA A, Szot W, Dziewiecka E, Boczar K, et al
Gated SPECT Imaging of Left Ventricular Mechanical Dyssynchrony: Predictive Value in Cardiac Resynchronization Therapy Candidates.
J Nucl Cardiol. 2026 Mar 28:102708. doi: 10.1016/j.nuclcard.2026.102708.
PubMed Abstract available

SAGER DF, Caflisch C, Giannopoulos AA, Pazhenkottil AP, et al
Temporal Changes in [13N]-Ammonia PET Myocardial Perfusion Imaging: Population Characteristics and Imaging Findings Over 25 Years.
J Nucl Cardiol. 2026 Mar 27:102705. doi: 10.1016/j.nuclcard.2026.102705.
PubMed

MOURA FA, Sinusas AJ
DOTA-Based Perfusion Imaging in Hybrid PET/MR: Promise, Limits, and the Importance of Tracer Kinetics.
J Nucl Cardiol. 2026 Mar 27:102703. doi: 10.1016/j.nuclcard.2026.102703.
PubMed

SHOKRAVI A, Miller RJH
Evaluating Deep Learning Attenuation Correction for SPECT MPI: Lessons From Clinical Validation.
J Nucl Cardiol. 2026 Mar 27:102701. doi: 10.1016/j.nuclcard.2026.102701.
PubMed

BOURQUE JM
ASNC's Cardiac PET Position Statement Is timely, with implications for PET and SPECT.
J Nucl Cardiol. 2026 Mar 13:102685. doi: 10.1016/j.nuclcard.2026.102685.
PubMed

MELHEM HB, Lanctot-Bedard J, Boulet J, Tadros R, et al
Resolution of Microvascular Ischemia Following Alcohol Septal Ablation in Hypertrophic Cardiomyopathy: Evidence from Rubidium-82 PET.
J Nucl Cardiol. 2026 Mar 12:102682. doi: 10.1016/j.nuclcard.2026.102682.
PubMed

UUSITALO V
Hybrid [(15)O]H(2)O PET/CTA Imaging Uncovers Microvascular Dysfunction in Cardiac Amyloidosis.
J Nucl Cardiol. 2026 Mar 11:102684. doi: 10.1016/j.nuclcard.2026.102684.
PubMed

PANG Z, Li Y, Cui L, Wang J, et al
Prognostic value of cardiac-dedicated CZT-SPECT dynamic imaging derived myocardial blood flow quantification parameters in post-PCI acute myocardial infarction patients: A pilot study.
J Nucl Cardiol. 2026 Mar 10:102681. doi: 10.1016/j.nuclcard.2026.102681.
PubMed Abstract available

WRIGHT CX, Schwann A, Mulinski T, Tegtmeyer K, et al
Atrial Wall FDG Uptake on Sarcoid FDG PET Corresponding with Right Atrial Appendage Thrombus.
J Nucl Cardiol. 2026 Mar 9:102683. doi: 10.1016/j.nuclcard.2026.102683.
PubMed

NGO V, Harel F, Finnerty V, Pelletier-Galarneau M, et al
Normal Values of Myocardial Blood Flow and Flow Reserve with Rubidium-82 PET in Low-Risk Patients.
J Nucl Cardiol. 2026 Mar 9:102680. doi: 10.1016/j.nuclcard.2026.102680.
PubMed Abstract available

MURPHY NP, Cremer PC
Quantifying what matters: Clarifying the value of longitudinal flow gradients in [82Rb]rubidium-positron emission tomography myocardial perfusion imaging.
J Nucl Cardiol. 2026;57:102648.
PubMed

KWIECINSKI J
Harnessing the full potential of positron emission tomography myocardial perfusion imaging with artificial intelligence.
J Nucl Cardiol. 2026;57:102593.
PubMed

NISHI T, Ota S, Shiono Y, Takano Y, et al
Value of single-photon emission computed tomography for diagnosing transthyretin amyloid cardiomyopathy: Correlation with endomyocardial biopsy.
J Nucl Cardiol. 2026;57:102595.
PubMed Abstract available

February 2026

AKHTER A, Sharmin S, Rahman F, Afrin R, et al
Looking Beyond the Myocardium: Incidental Detection of Malignant Neoplasm Through Ectopic (18)F-FDG Uptake on Cardiac PET Viability Imaging.
J Nucl Cardiol. 2026 Feb 24:102676. doi: 10.1016/j.nuclcard.2026.102676.
PubMed

KERO T, Kvernby S, Eggers KM, Rischpler C, et al
Evaluation of Gd-DOTA as a marker for myocardial blood flow using (68)Ga-DOTA and (15)O-water PET.
J Nucl Cardiol. 2026 Feb 23:102671. doi: 10.1016/j.nuclcard.2026.102671.
PubMed Abstract available

SARASTE A, Knuuti J
New opportunities for nuclear cardiology with total-body PET/CT.
J Nucl Cardiol. 2026 Feb 2:102652. doi: 10.1016/j.nuclcard.2026.102652.
PubMed Abstract available

IQBAL I, Liljenback H, Andriana P, Stahle M, et al
Folate receptor ss-targeted PET imaging of activated macrophages in experimental myocardial infarction.
J Nucl Cardiol. 2026 Feb 2:102653. doi: 10.1016/j.nuclcard.2026.102653.
PubMed Abstract available

DI CARLI MF
SPECT's next act in nuclear cardiology.
J Nucl Cardiol. 2026;56:102655.
PubMed

TERSALVI G, Carey P, Garmany A, Scott CG, et al
Comparative performance of (99m)Tc-pyrophosphate vs. (99m)Tc-hydroxymethylene diphosphonate for cardiac amyloid radionuclide imaging.
J Nucl Cardiol. 2026;56:102587.
PubMed Abstract available

MARTIN EB, Kassira A, Stuckey A, Whittle B, et al
A tale of two tracers - amyloid imaging with investigational radiotracers iodine ((124)I) evuzamitide and (99m)Tc-p5+14 (AT-05).
J Nucl Cardiol. 2026;56:102451.
PubMed Abstract available

HAGERMAN J, Engblom SA, Andelius IC, Stenvall A, et al
Assessment of myocardial sympathetic innervation with [(123)I]mIBG myocardial scintigraphy: A comparative study between an Anger and a ring-configured cadmium-zinc-telluride gamma camera.
J Nucl Cardiol. 2026;56:102574.
PubMed Abstract available

January 2026

ALWAN M, El Yaman A, Al Rifai M, Escobar S, et al
Optimizing Protocol Efficiency in [(18)F]Flurpiridaz PET MPI Through Dose Ratio-Driven Reduction of Relative Residual Activity.
J Nucl Cardiol. 2026 Jan 30:102644. doi: 10.1016/j.nuclcard.2026.102644.
PubMed Abstract available

KOUNGA C, Ciuffo L, Shiyovich A, Divakaran S, et al
Significant Vasodilator-Induced Hypotension: A Mimic of Vasodilator Non-Responsiveness in PET/CT Myocardial Perfusion Imaging.
J Nucl Cardiol. 2026 Jan 29:102639. doi: 10.1016/j.nuclcard.2026.102639.
PubMed

ALDAJANI A, Kadoya Y, Small G, Chow B, et al
Isolated Transient Ischemic Dilation in Hypertrophic Cardiomyopathy: A PET Imaging Paradox with Preserved Myocardial Flow Reserve.
J Nucl Cardiol. 2026 Jan 23:102651. doi: 10.1016/j.nuclcard.2026.102651.
PubMed

AMBROSINI AP, Vashist A, Sinusas A, Moura FA, et al
Low-Dose CT as a Diagnostic Clue: Unmasking Anemia as a Cause of Reduced Myocardial Flow Reserve on PET/CT.
J Nucl Cardiol. 2026 Jan 22:102646. doi: 10.1016/j.nuclcard.2026.102646.
PubMed

HIJAZI W, Slomka PJ
Left ventricular function across SPECT, PET, and magnetic resonance imaging (MRI): Consistency remains elusive.
J Nucl Cardiol. 2026;55:102577.
PubMed

SVANSTROM P, Kero T, Polte CL, Sigfridsson J, et al
Impact of hemoglobin concentration on quantitative cardiac perfusion measurements.
J Nucl Cardiol. 2026;55:102537.
PubMed Abstract available

KATOH S, Watanabe T, Mito T, Hashimoto N, et al
Single-photon emission computed tomography-increase ratio, a potential alternative to positron emission tomography-myocardial flow reserve, is a useful prognostic indicator in patients with known or suspected coronary heart disease at facilities witho
J Nucl Cardiol. 2026;55:102536.
PubMed Abstract available

December 2025

Clinical Indications for PET Myocardial Perfusion Imaging and Myocardial Blood Flow Quantification: An American Society of Nuclear Cardiology (ASNC) Position Statement.
J Nucl Cardiol. 2025 Dec 31:102619. doi: 10.1016/j.nuclcard.2025.102619.
PubMed

TORRES ORDONEZ A, Akincioglu C, Soman P, Kanitsorphan C, et al
Diagnostic Discordance between Planar and SPECT Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
J Nucl Cardiol. 2025 Dec 18:102618. doi: 10.1016/j.nuclcard.2025.102618.
PubMed Abstract available

LABIENIEC L, Szymanski KR, Andrejczuk A, Spyridonidis TJ, et al
Single versus double computed tomography scan for attenuation correction in SPECT stress-rest myocardial perfusion studies: from polar maps similarity to clinical impact.
J Nucl Cardiol. 2025 Dec 16:102607. doi: 10.1016/j.nuclcard.2025.102607.
PubMed Abstract available

GUNASEKARAN V, Singh H, Panda P, Bhasin D, et al
Assessment of Coronary Microvascular Dysfunction in INOCA Patients Using (13)N-Ammonia-PET: Lack of Correlation with Angiographic Flow Grades.
J Nucl Cardiol. 2025 Dec 15:102596. doi: 10.1016/j.nuclcard.2025.102596.
PubMed Abstract available

VILAIN D, Cobes N, Girma A, Amar R, et al
Regional Myocardial Uptake in Routine Oncologic (18)F-FDG PET/CT Studies and Coronary Artery Disease.
J Nucl Cardiol. 2025 Dec 11:102592. doi: 10.1016/j.nuclcard.2025.102592.
PubMed

MISHRA M, Taywade S, Kumar R, Patel S, et al
A Case of Early Prosthetic Valve Endocarditis Complicated with Large Pseudoaneurysm: The Role of 18F-FDG PET/CT in Initial and Follow-up Evaluation.
J Nucl Cardiol. 2025 Dec 11:102594. doi: 10.1016/j.nuclcard.2025.102594.
PubMed

MANNAN ZM, Hankinson SJ, Laychak SS, Hainer J, et al
Prevalence of Lateral Wall Myocardial FDG Uptake in Patients with Left Bundle Branch Block or Ventricular Pacing Referred for Sarcoidosis FDG PET/CT Imaging.
J Nucl Cardiol. 2025 Dec 4:102581. doi: 10.1016/j.nuclcard.2025.102581.
PubMed Abstract available

FUJITO H, Gransar H, Park RH, Han D, et al
Dual Assessment of CAC and Exercise Ability Enhances Mortality Prediction in Stress SPECT-MPI Patients.
J Nucl Cardiol. 2025 Dec 3:102582. doi: 10.1016/j.nuclcard.2025.102582.
PubMed Abstract available

LIGA R, Filidei E, Runza G, Gimelli A, et al
Accuracy of myocardial perfusion imaging in older patients: Insights from a sub-analysis of the AMICO registry.
J Nucl Cardiol. 2025;54:102530.
PubMed Abstract available

ALWAN M, El Yaman A, Sayed A, Shaikh A, et al
Cardiac nuclear imaging workforce: Trends from Medicare Part B (2013-2022).
J Nucl Cardiol. 2025;54:102472.
PubMed Abstract available

November 2025

KADOYA Y, Boczar K, Tavoosi A, Small GR, et al
Diagnostic Utility of Longitudinal Flow Gradient for Diagnosis of Obstructive CAD in Rubidium-82 Positron Emission Tomography.
J Nucl Cardiol. 2025 Nov 29:102586. doi: 10.1016/j.nuclcard.2025.102586.
PubMed Abstract available

AHMED AI, Csecs I, Wright C, Kyriakoulis I, et al
A Comparative Analysis of CZT SPECT/CT to Conventional SPECT and PET: Implications for Risk Stratification.
J Nucl Cardiol. 2025 Nov 29:102583. doi: 10.1016/j.nuclcard.2025.102583.
PubMed

SARWAR S, Kadoya Y, Small GR, Chow BJW, et al
Positron Emission Tomography Myocardial Perfusion Imaging Findings in Patients with Systemic Vasculitis.
J Nucl Cardiol. 2025 Nov 28:102580. doi: 10.1016/j.nuclcard.2025.102580.
PubMed

MILLER RJH, Shanbhag A, Shahi K, Bosley D, et al
Artificial Intelligence-Driven Longitudinal Quantification of Technetium Pyrophosphate Uptake in Cardiac Amyloidosis: Correlation with Multimodality Imaging and Outcomes.
J Nucl Cardiol. 2025 Nov 26:102573. doi: 10.1016/j.nuclcard.2025.102573.
PubMed Abstract available

APHALE P, Shekhar H, Dokania S
Refining Quantitative SPECT/CT in Transthyretin Cardiac Amyloidosis: Toward Standardized Clinical Application.
J Nucl Cardiol. 2025 Nov 26:102571. doi: 10.1016/j.nuclcard.2025.102571.
PubMed

ZHANG D, Gu Y, Liu H, Ding D, et al
Pharmacokinetic modelling of dynamic (99m)Tc-4BOH SPECT for myocardial perfusion imaging in patients with coronary artery disease.
J Nucl Cardiol. 2025 Nov 21:102570. doi: 10.1016/j.nuclcard.2025.102570.
PubMed Abstract available

SPERRY BW, Godwin LA, Hutt E, Case JA, et al
Quantitative Changes Between 1 and 3 hours in Technetium Pyrophosphate Cardiac Amyloid SPECT Imaging.
J Nucl Cardiol. 2025 Nov 21:102568. doi: 10.1016/j.nuclcard.2025.102568.
PubMed

WANG K, Li X, Song S, Li H, et al
Quantifying Right Ventricular Fibrosis Burden in CTEPH via FAPI SPECT/CT: Correlation with Echocardiographic Parameters and BPA Response.
J Nucl Cardiol. 2025 Nov 20:102565. doi: 10.1016/j.nuclcard.2025.102565.
PubMed Abstract available

NIELSEN MO, Lassen ML, Zerahn B, Kjaer A, et al
Evaluation of Rest (82)Rb PET as an Alternative to (99m)Tc-Based Monitoring of Cardiac Function During Chemotherapy.
J Nucl Cardiol. 2025 Nov 20:102567. doi: 10.1016/j.nuclcard.2025.102567.
PubMed

ASSANTE R, Zampella E, D'Antonio A, Mannarino T, et al
Improved risk stratification with non-invasive measures of myocardial flow reserve by low-dose dynamic imaging by CZT-SPECT in patients with suspected or known CAD.
J Nucl Cardiol. 2025 Nov 20:102564. doi: 10.1016/j.nuclcard.2025.102564.
PubMed

SHAIKH A, Alwan M, Sayed A, El-Yaman A, et al
Obesity Based Modulation of PET Myocardial Blood Flow Reserve.
J Nucl Cardiol. 2025 Nov 13:102538. doi: 10.1016/j.nuclcard.2025.102538.
PubMed

HEDEER F, Kvernby S, Oddstig J, Engblom SA, et al
Head-to-head comparison of left ventricular volumes and ejection fraction by [(13)N]ammonia positron emission tomography, myocardial perfusion single-photon emission computed tomography with cadmium-zinc-telluride technology and cardiac magnetic reson
J Nucl Cardiol. 2025 Nov 7:102542. doi: 10.1016/j.nuclcard.2025.102542.
PubMed Abstract available

KHAN MS, Bateman TM, Case JA, Sperry BW, et al
Beyond Flow Reserve: Comparative Prognostic Value of Myocardial Blood Flow Reserve, Peak Stress Myocardial Blood Flow, and Blood Flow Reserve Corrected for Resting Rate Pressure Product in Patients Undergoing PET Myocardial Perfusion Imaging.
J Nucl Cardiol. 2025 Nov 6:102540. doi: 10.1016/j.nuclcard.2025.102540.
PubMed Abstract available

DOUKKY R
Heart Rate Response to Regadenoson Stress with PET MPI: Old Marker, New Insights.
J Nucl Cardiol. 2025 Nov 5:102557. doi: 10.1016/j.nuclcard.2025.102557.
PubMed

FEHER A, Sinusas AJ
Confirming Expectations - Coronary Artery Calcification Assessment Provides Diagnostic Value in F18-flurpiridaz PET Myocardial Perfusion Imaging.
J Nucl Cardiol. 2025 Nov 4:102559. doi: 10.1016/j.nuclcard.2025.102559.
PubMed

KERO T, Knuuti J, Bar S, Bax JJ, et al
Stenosis degree and plaque burden differ between the major epicardial coronary arteries supplying ischemic territories.
J Nucl Cardiol. 2025;53:102470.
PubMed Abstract available

MAHDI RA, Singh H, Ilangovan J, Dahiya N, et al
Coronary anatomy matters: Dual LAD presenting as atypical ischemia on myocardial perfusion imaging.
J Nucl Cardiol. 2025;53:102205.
PubMed Abstract available

October 2025

MAJOR JD, Weinberg RL, Bourgeault BIng V, Harel F, et al
Reduced Occupational Radiation Exposure After Rubidium-82 PET Adoption: A 10-Year Observational Study.
J Nucl Cardiol. 2025 Oct 31:102541. doi: 10.1016/j.nuclcard.2025.102541.
PubMed

ALAHDAB F, El Shawi R, Ahmed AI, Al Rifai M, et al
Improving Prognostic Risk Assessment of Cardiovascular Events with Machine Learning: An Evaluation Using PET Myocardial Perfusion Imaging.
J Nucl Cardiol. 2025 Oct 30:102539. doi: 10.1016/j.nuclcard.2025.102539.
PubMed Abstract available

SOBY JH, Mortensen J, Rasmussen LD, Tolbod LP, et al
Systematic Differences in Myocardial Blood Flow and Flow Reserve Quantification Using Rubidium-82 and [(15)O]H(2)O PET: Implications for Prognostic Cut-Offs.
J Nucl Cardiol. 2025 Oct 17:102533. doi: 10.1016/j.nuclcard.2025.102533.
PubMed Abstract available

HYUN MC, Brown A, Calnon DA
SCANNER ROOM CRISIS: Bridging THE WORKFORCE SHORTAGE GAP of Nuclear Medicine Technologists.
J Nucl Cardiol. 2025 Oct 17:102527. doi: 10.1016/j.nuclcard.2025.102527.
PubMed

BARRETT O, Shanbhag A, Zaid R, Miller RJH, et al
Incremental diagnostic value of AI-derived coronary artery calcium in (18)F-flurpiridaz PET Myocardial Perfusion Imaging.
J Nucl Cardiol. 2025 Oct 14:102532. doi: 10.1016/j.nuclcard.2025.102532.
PubMed Abstract available

LIMA RSL, de Lorenzo A, Palazzo IC, Mesquita CT, et al
How to Perform Quantification of Myocardial Blood Flow using SPECT MPI How to use Nuclear Cardiology.
J Nucl Cardiol. 2025 Oct 14:102534. doi: 10.1016/j.nuclcard.2025.102534.
PubMed

MOULTON E, Gagliano L, Kaviani S, Klein R, et al
Artificial Intelligence-enabled parametric mapping of myocardial blood flow with (82)Rb PET compared to (18)F-flurpiridaz perfusion imaging: A paired pilot study of image quality.
J Nucl Cardiol. 2025 Oct 13:102531. doi: 10.1016/j.nuclcard.2025.102531.
PubMed

WANG Y
Beyond Rest-Stress: Expanding Rapid (18)F-Flurpiridaz PET to Post-Stress Viability and Quantifying Coronary Flow Reserve.
J Nucl Cardiol. 2025 Oct 10:102529. doi: 10.1016/j.nuclcard.2025.102529.
PubMed

SAYED A, Al Rifai M, El Yaman A, Alwan M, et al
Differential Association of Heart Rate Response to Regadenoson with Death and Heart Failure Hospitalizations According to Ejection Fraction in Patients Undergoing PET MPI.
J Nucl Cardiol. 2025 Oct 8:102508. doi: 10.1016/j.nuclcard.2025.102508.
PubMed Abstract available

ACAMPA W, Cantoni V
Positron emission tomography computed tomography versus cadmium zinc telluride single-photon emission computer tomography in myocardial flow quantification: Bridging the gap or replacing a standard?
J Nucl Cardiol. 2025;52:102443.
PubMed

DI CARLI MF
What if SPECT could do it all?
J Nucl Cardiol. 2025;52:102510.
PubMed

CSECS I, Sharma A, Khungar V, Sinusas AJ, et al
Blunted hemodynamic response to pharmacological stress is predictive of mortality in liver transplant candidates.
J Nucl Cardiol. 2025;52:102454.
PubMed Abstract available

September 2025

PASCALE R, Fernandez-Hidalgo N, Tazza B, Bartoletti M, et al
How to manage patients receiving long-term suppressive antibiotic treatment for infective endocarditis: the role of [18F]-FDG-PET/CT imaging - An international multidisciplinary survey.
J Nucl Cardiol. 2025 Sep 27:102505. doi: 10.1016/j.nuclcard.2025.102505.
PubMed

KHAN MS, Perumalla HS, Modi K, Asif T, et al
National Trends in Radiopharmaceutical Use for the Diagnosis of Cardiac Amyloidosis from 2019-2024.
J Nucl Cardiol. 2025 Sep 26:102502. doi: 10.1016/j.nuclcard.2025.102502.
PubMed

DALEBOUT EM, Hirsch A, Mulders TA, Segbers M, et al
Optimization of timing window and gating method for (18)F-FDG PET/CT in patients with suspected prosthetic valve endocarditis: A prospective pilot study.
J Nucl Cardiol. 2025 Sep 20:102501. doi: 10.1016/j.nuclcard.2025.102501.
PubMed

PACKARD RRS, Maddahi J, Pelletier-Galarneau M, Al-Mallah MH, et al
SNMMI/EANM/ASNC/ACNM procedure standard/practice guideline for (18)F-Flurpiridaz PET myocardial perfusion imaging and blood flow quantitation.
J Nucl Cardiol. 2025 Sep 18:102473. doi: 10.1016/j.nuclcard.2025.102473.
PubMed Abstract available

MILLER RJH, Barrett O, Shanbhag A, Rozanski A, et al
Integrating Perfusion with AI-derived Coronary Calcium on CT attenuation scans to improve selection of low-risk studies for stress-only SPECT MPI.
J Nucl Cardiol. 2025 Sep 10:102482. doi: 10.1016/j.nuclcard.2025.102482.
PubMed Abstract available

LIMA BB, Kronenberg MW, Carr CM, Duran J, et al
How to Prepare Patients for (18)F-FDG PET Myocardial Viability Assessment.
J Nucl Cardiol. 2025 Sep 2:102480. doi: 10.1016/j.nuclcard.2025.102480.
PubMed

AJIMA T, Aikawa T, Saitou T, Matsue Y, et al
Prognostic value of (99m)Tc-pyrophosphate uptake in patients with suspected transthyretin cardiac amyloidosis.
J Nucl Cardiol. 2025;51:102452.
PubMed Abstract available

BENZ DC, Flammer AJ, Schwotzer R, Buechel RR, et al
How to perform and interpret cardiac amyloidosis radionuclide imaging (CARI).
J Nucl Cardiol. 2025;51:102448.
PubMed Abstract available

August 2025

RAMIREZ G, Lemley M, Shanbhag A, Kwiecinski J, et al
The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET(REFINE PET): Rationale and Design.
J Nucl Cardiol. 2025 Aug 5:102449. doi: 10.1016/j.nuclcard.2025.102449.
PubMed Abstract available

SCHERPING SC 3RD, Ahmad SM, Katz SM, Hosadurg N, et al
The prevalence and prognostic impact of additive abnormal stress exercise markers in patients with normal stress myocardial perfusion imaging.
J Nucl Cardiol. 2025;50:102267.
PubMed Abstract available

July 2025

RENAUD JM, Moody JB, Vanderver MD, Poitrasson-Riviere A, et al
Improved diagnostic performance of (18)F-flurpiridaz PET myocardial blood flow quantification with automated dynamic motion correction.
J Nucl Cardiol. 2025 Jul 25:102450. doi: 10.1016/j.nuclcard.2025.102450.
PubMed

CLAUDIO FD, Siddiqui S, Gil FR, Morley-Smith A, et al
Unmasking Deep Sternal Wound Infection After Cardiac Transplant: The Diagnostic and Monitoring Value of (18)F-FDG PET/CT.
J Nucl Cardiol. 2025 Jul 25:102447. doi: 10.1016/j.nuclcard.2025.102447.
PubMed

GU Y, Sun R, Ren W, Xi X, et al
Preclinical and first-in-human studies of a novel tracer for SPECT myocardial blood flow quantification.
J Nucl Cardiol. 2025 Jul 15:102441. doi: 10.1016/j.nuclcard.2025.102441.
PubMed Abstract available

WANG S, Luan Q, Cheng Z, Li Y, et al
(18)F-FAP-2286 and (18)F-FDG PET/CT imaging in a rare case of asymptomatic indolent cardiac hemangioma in the right ventricle.
J Nucl Cardiol. 2025 Jul 15:102442. doi: 10.1016/j.nuclcard.2025.102442.
PubMed

HIJAZI W, Feng Y, Southern DA, Chew D, et al
Corrigendum to "Association of medical therapies with survival according to SPECT MPI findings" [J Nucl Cardiol 3 May 2025; 102229].
J Nucl Cardiol. 2025 Jul 15:102440. doi: 10.1016/j.nuclcard.2025.102440.
PubMed

ALI SM, Sathian B, Iqbal J, Muhammad K, et al
Caution in Interpreting PET-Negative Fibrosis: Commentary on the Diagnostic Scope of 13N-Ammonia PET in Non-Ischemic Cardiomyopathies.
J Nucl Cardiol. 2025 Jul 8:102300. doi: 10.1016/j.nuclcard.2025.102300.
PubMed

BROWN JM, Huck DM
Total-Body PET: Investigating Mechanisms in Cardiovascular-Kidney-Metabolic Syndrome.
J Nucl Cardiol. 2025 Jul 5:102299. doi: 10.1016/j.nuclcard.2025.102299.
PubMed Abstract available

WRIGHT CX, Spatz ES
Leveraging stress testing as a risk modifier: Optimization of medical therapy after SPECT MPI.
J Nucl Cardiol. 2025;49:102282.
PubMed

AL RIFAI M, Ahmed AI, Nayfeh M, Nabi F, et al
The prognostic significance of rate pressure product corrected myocardial flow reserve.
J Nucl Cardiol. 2025;49:102222.
PubMed Abstract available

June 2025

SPILLER WH, SathyaMurthi B, Arumugam P
Unexpected insight: Rubidium-82 PET/CT myocardial perfusion imaging uncovers malignant pleural mesothelioma.
J Nucl Cardiol. 2025 Jun 16:102264. doi: 10.1016/j.nuclcard.2025.102264.
PubMed

YAHIRO DS, Silva LFLD, Junior GL, Al-Mallah MH, et al
Comparison of PET-CT and CZT-SPECT on Myocardial Blood Flow and Flow Reserve measurement: a systematic review and meta-analysis.
J Nucl Cardiol. 2025 Jun 15:102279. doi: 10.1016/j.nuclcard.2025.102279.
PubMed Abstract available

RENAUD JM, Moody JB, Vanderver MD, Poitrasson-Riviere A, et al
Diagnostic performance of (18)F-flurpiridaz PET myocardial perfusion imaging with total perfusion deficit quantification.
J Nucl Cardiol. 2025 Jun 15:102266. doi: 10.1016/j.nuclcard.2025.102266.
PubMed Abstract available

MALIK AP, Parvez Malik UF, Iqbal J, Sathian B, et al
Comment on "Validation of [99mTc]Tc-HMDP SPECT/CT Myocardial Uptake Quantification for the Detection of ATTR Cardiomyopathy".
J Nucl Cardiol. 2025 Jun 13:102272. doi: 10.1016/j.nuclcard.2025.102272.
PubMed

LEGALLOIS D, Turcan L, Agostini D, Manrique A, et al
Test-retest Reproducibility of Myocardial (99m)Tc-HMDP Uptake Quantification by SPECT-CT in Suspected Transthyretin Cardiac Amyloidosis.
J Nucl Cardiol. 2025 Jun 13:102273. doi: 10.1016/j.nuclcard.2025.102273.
PubMed Abstract available

ROMERO PABON AJ, Clerc OF, Cuddy SAM, Vijayakumar S, et al
Prognostic Value of (99m)technetium-PYP SPECT Visual Grade in Patients with Transthyretin Cardiac Amyloidosis on Stabilization Therapy.
J Nucl Cardiol. 2025 Jun 13:102275. doi: 10.1016/j.nuclcard.2025.102275.
PubMed Abstract available

CROWLEY LE, Jenkins E, Ranasinghe A, Naneishvili T, et al
Serial (18)F-Fluorodeoxyglucose Positron Emission Tomography to Assess the Efficacy of Infliximab in Steroid Refractory Cardiac Sarcoidosis.
J Nucl Cardiol. 2025 Jun 9:102265. doi: 10.1016/j.nuclcard.2025.102265.
PubMed

KADRMAS DJ, Kemp BJ, Sitek A, Chareonthaitawee P, et al
Technical Evaluation of Immediate Back-to-Back Rest-Stress PET Scanning with (18)F-Flurpiridaz.
J Nucl Cardiol. 2025 Jun 9:102268. doi: 10.1016/j.nuclcard.2025.102268.
PubMed Abstract available

FUJITO H, Lemley M, Builoff V, Zhang W, et al
(82)Rb PET Myocardial Blood Flow Quantification: Influence of Arterial Input Curve Quality on Diagnostic Accuracy.
J Nucl Cardiol. 2025 Jun 7:102270. doi: 10.1016/j.nuclcard.2025.102270.
PubMed Abstract available

MANABE O
AI-driven quantification in (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: A step toward objectivity and reproducibility.
J Nucl Cardiol. 2025;48:102224.
PubMed

AL RIFAI M, Alwan M, Ahmed AI, Nabi F, et al
The impact of obesity on myocardial flow reserve and its prognostic utility.
J Nucl Cardiol. 2025;48:102193.
PubMed Abstract available

May 2025

ALWAN M, Sayed A, Ahmed AI, Shaikh A, et al
The Impact of Attenuation Correction and Prone Positioning on Stress-Only Imaging in Cardiac SPECT: An Observational Study.
J Nucl Cardiol. 2025 May 20:102249. doi: 10.1016/j.nuclcard.2025.102249.
PubMed Abstract available

DALEBOUT EM, Swart LE, Kluin J, Weustink AC, et al
(18)F-FDG PET-CT in patients with prosthetic heart valves: variations in imaging findings: A review of the literature.
J Nucl Cardiol. 2025 May 17:102247. doi: 10.1016/j.nuclcard.2025.102247.
PubMed Abstract available

ALWAN M, El Yaman A, Sayed A, Shaikh A, et al
Cardiac Positron emission tomography/ computed tomography (PET/CT) in current cardiology guidelines.
J Nucl Cardiol. 2025 May 8:102231. doi: 10.1016/j.nuclcard.2025.102231.
PubMed Abstract available

HIJAZI W, Feng Y, Southern DA, Chew D, et al
Association of Medical Therapies with Survival According to SPECT MPI Findings.
J Nucl Cardiol. 2025 May 3:102229. doi: 10.1016/j.nuclcard.2025.102229.
PubMed Abstract available

OSBORNE MT, Al-Mallah MH
Probing the shadows of myocardial scar: Can PET MPI see what MRI sees?
J Nucl Cardiol. 2025;47:102221.
PubMed

LEE SN, Malhotra P, Miller RJH, Gransar H, et al
Independent prognostic significance of myocardial flow reserve over coronary artery calcium, myocardial perfusion, and clinical variables in patients without known coronary artery disease, according to diabetes status.
J Nucl Cardiol. 2025;47:102165.
PubMed Abstract available

HSU TJ, Tseng CT, Kuo L, Yang CY, et al
AHL amyloidosis mimicking transthyretin amyloidosis on cardiac Tc-99 m pyrophosphate scan: A diagnostic challenge.
J Nucl Cardiol. 2025;47:102147.
PubMed Abstract available

April 2025

SPRAUEL T, Imbert L, Doyeux K, Perrin M, et al
Assessment of Sestamibi CZT-SPECT Reconstructed Using Deep-Learning-Based Virtual Attenuation Correction Maps According to Coronary Artery Territory and With Comparison to Rubidium-PET.
J Nucl Cardiol. 2025 Apr 19:102226. doi: 10.1016/j.nuclcard.2025.102226.
PubMed Abstract available

SHINN K, Henderson CS, Schenone AL, Goonewardena SN, et al
Can ChatGPT answer patients' questions about nuclear stress tests and (18)F-Flurodeoxyglucose PET for myocardial inflammation?
J Nucl Cardiol. 2025 Apr 5:102174. doi: 10.1016/j.nuclcard.2025.102174.
PubMed Abstract available

DIVAKARAN S, Harms HJ, Robertson M, Merugumala SK, et al
Post-walking exercise skeletal muscle perfusion and energetics in patients with symptomatic lower extremity peripheral artery disease.
J Nucl Cardiol. 2025;46:102143.
PubMed Abstract available

CALLEGARI S, Mena-Hurtado C, Smolderen KG, Thorn S, et al
New horizons in nuclear cardiology: Imaging of peripheral arterial disease.
J Nucl Cardiol. 2025;46:102079.
PubMed Abstract available

March 2025

SUOMALAINEN O, Ahokas T, Hippelainen E, Helio T, et al
Validation of [(99m)Tc]Tc-HMDP SPECT/CT Myocardium-to-blood Ratio for the Detection of ATTR Cardiomyopathy.
J Nucl Cardiol. 2025 Mar 28:102199. doi: 10.1016/j.nuclcard.2025.102199.
PubMed Abstract available

NAZIF K, Abuzaid AS, Horgan S, Patel KK, et al
Role of Rubidium-82 positron emission tomography in a multimodality approach to diagnosing Coronary Microvascular Dysfunction in Apical Hypertrophic Cardiomyopathy.
J Nucl Cardiol. 2025 Mar 25:102197. doi: 10.1016/j.nuclcard.2025.102197.
PubMed

NIKOLAKOPOULOS I, Csecs I, Liu YH, Sinusas AJ, et al
Temporal changes in PET myocardial flow reserve: implications for cardiovascular outcomes.
J Nucl Cardiol. 2025 Mar 24:102194. doi: 10.1016/j.nuclcard.2025.102194.
PubMed Abstract available

MILLER RJ, Shanbhag A, Marcinkiewicz AM, Struble H, et al
AI-enabled CT-guided end-to-end quantification of total cardiac activity in 18FDG cardiac PET/CT for detection of cardiac sarcoidosis.
J Nucl Cardiol. 2025 Mar 22:102195. doi: 10.1016/j.nuclcard.2025.102195.
PubMed Abstract available

HEINIGER PS, Igual GD, Galafton A, Albertini T, et al
Impact of transmurality and location on the diagnostic performance of 13N-ammonia PET in the detection of myocardial fibrosis - A hybrid PET/MR study.
J Nucl Cardiol. 2025 Mar 1:102172. doi: 10.1016/j.nuclcard.2025.102172.
PubMed Abstract available

PERRIN M, Claudin M, Djaballah K, Boursier C, et al
Diagnostic accuracy of low-dose myocardial perfusion imaging in a real-world setting.
J Nucl Cardiol. 2025;45:102140.
PubMed Abstract available

BUILOFF V, Shanbhag A, Miller RJ, Dey D, et al
Evaluating AI proficiency in nuclear cardiology: Large language models take on the board preparation exam.
J Nucl Cardiol. 2025;45:102089.
PubMed Abstract available

BOURQUE JM, Beanlands RSB, Berman DS, Chareonthaitawee P, et al
F-18 flurpiridaz positron emission tomography myocardial perfusion imaging combined with treadmill exercise testing.
J Nucl Cardiol. 2025;45S:102170.
PubMed

MADDAHI J
(18)F flurpiridaz PET MPI: Imaging characteristics and clinical trials.
J Nucl Cardiol. 2025;45S:102175.
PubMed

PATEL KK, Horgan S, Heller GV, Bateman TM, et al
F-18-Flurpiridaz positron emission tomography myocardial perfusion imaging clinical results in specific patient populations.
J Nucl Cardiol. 2025;45S:102166.
PubMed

DI CARLI MF
The rise of quantitative positron emission tomography: Redefining the evaluation of coronary artery disease.
J Nucl Cardiol. 2025;45S:102179.
PubMed

AL-MALLAH MH, Al Badarin F, Bengel F, Grossman GB, et al
Potential worldwide impact of F-18 Flurpiridaz positron emission tomography myocardial perfusion imaging.
J Nucl Cardiol. 2025;45S:102167.
PubMed

PACKARD RRS, deKemp RA, Knuuti J, Moody JB, et al
Quantitative approaches to (18)F-flurpiridaz positron emission tomography image analysis.
J Nucl Cardiol. 2025;45S:102180.
PubMed

February 2025

OMOTE K, Oi M, Aikawa T
Serial assessment of DWIBS-MRI and (18)F-fluorodexyglcose PET/CT after corticosteroid therapy in Takayasu arteritis.
J Nucl Cardiol. 2025 Feb 28:102171. doi: 10.1016/j.nuclcard.2025.102171.
PubMed

XIE H, Alashi A, Thorn SL, Chen X, et al
Increasing angular sampling for dedicated cardiac SPECT scanner: Implementation with Deep Learning and Validation with human data.
J Nucl Cardiol. 2025 Feb 20:102168. doi: 10.1016/j.nuclcard.2025.102168.
PubMed

MOU T, Meng J, Lin C, Xie X, et al
XTR003, a Fatty-acid Metabolism PET Tracer: A Phase I Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics in Healthy Volunteers.
J Nucl Cardiol. 2025 Feb 7:102144. doi: 10.1016/j.nuclcard.2025.102144.
PubMed Abstract available

TUBBEN A, Prakken NHJ, Ivashchenko OV, Tingen HSA, et al
Feasibility of the Absolute Quantification and Left Ventricular Segmentation of Cardiac Sympathetic Innervation in Wild-type Transthyretin Amyloidosis Cardiomyopathy with [(123)I]-MIBG SPECT/CT: the I-NERVE study.
J Nucl Cardiol. 2025 Feb 3:102146. doi: 10.1016/j.nuclcard.2025.102146.
PubMed Abstract available

NYE JA, Tipnis SV
Addressing motion in the estimation of myocardial blood flow with [F-18] flurpiridaz positron emission tomography.
J Nucl Cardiol. 2025;44:102123.
PubMed

RISCHPLER C
'TIDing' over the uncertainty: Prognostic value of Transient Ischemic Dilation in Rubidium-82 PET myocardial perfusion imaging.
J Nucl Cardiol. 2025;44:102142.
PubMed

MENGESHA B, Small G, Paterson DI, Chow B, et al
Transient ischemic dilatation in cardiac amyloidosis.
J Nucl Cardiol. 2025;44:102042.
PubMed Abstract available

January 2025

WIEFELS C, Boczar K, Birnie D, Beanlands R, et al
Quantification of metabolic activity in the evaluation of cardiac sarcoidosis.
J Nucl Cardiol. 2025;43:102088.
PubMed Abstract available

TORRES A, Yerkan A, Abbasi A, Doukky R, et al
The prognostic utility of heart rate and blood pressure response to regadenoson stress.
J Nucl Cardiol. 2025;43:102050.
PubMed Abstract available

VEERWAL H, Preet K, Sood A, Singh H, et al
Incidentally detected diaphragmatic eventration as para-cardiac thoracic activity on myocardial perfusion imaging.
J Nucl Cardiol. 2025;43:101817.
PubMed Abstract available

December 2024

LOGANATH K, Craig N, Barton A, Joshi S, et al
Cardiovascular PET imaging of fibroblast activation A review of the current literature.
J Nucl Cardiol. 2024 Dec 11:102106. doi: 10.1016/j.nuclcard.2024.102106.
PubMed Abstract available

WU J, Young BD, Liu H, Sadeghi MM, et al
Parametric FDG PET K(i) images using dual-time-point imaging data for cardiac sarcoidosis: a proof of concept study.
J Nucl Cardiol. 2024 Dec 7:102121. doi: 10.1016/j.nuclcard.2024.102121.
PubMed

CLERC OF, Saraste A
The heart has a memory: Let's not forget to interrogate it with (18)F-FDG PET.
J Nucl Cardiol. 2024;42:102087.
PubMed

ZHANG F, Yang X, Chen Y, Shao X, et al
Incremental prognostic value of (18)F-fluorodeoxyglucose myocardial ischemic memory imaging for major adverse cardiovascular events in patients with suspected unstable angina.
J Nucl Cardiol. 2024;42:102051.
PubMed Abstract available

LUCINIAN YA, Martineau P, Abikhzer G, Harel F, et al
Novel tracers to assess myocardial inflammation with radionuclide imaging.
J Nucl Cardiol. 2024;42:102012.
PubMed Abstract available

November 2024

MOTWANI M
I can see clearly now the blur has gone - deep learning efficiencies in SPECT myocardial perfusion imaging.
J Nucl Cardiol. 2024 Nov 30:102091. doi: 10.1016/j.nuclcard.2024.102091.
PubMed

ROJULPOTE C, Bhattaru A, Patil S, Adams SL, et al
Assessing the Effect of Repeat PET Imaging on Treatment Response and Cardiovascular Outcomes among a Homogenously Treated Cohort of Patients with Suspected Cardiac Sarcoidosis.
J Nucl Cardiol. 2024 Nov 21:102082. doi: 10.1016/j.nuclcard.2024.102082.
PubMed Abstract available

KHOO CY, Maning J, Weinberg R, Avery R, et al
Correlation between Technetium-99m pyrophosphate myocardial uptake and extracellular volume on cardiac magnetic resonance imaging in patients with transthyretin cardiac amyloidosis.
J Nucl Cardiol. 2024 Nov 19:102083. doi: 10.1016/j.nuclcard.2024.102083.
PubMed

PATEL KK, Lim P, Peri-Okonny PA, Singh A, et al
Prognostic value of Transient Ischemic Dilation on Rubidium-82 Positron Emission Tomography Myocardial Perfusion Imaging.
J Nucl Cardiol. 2024 Nov 16:102084. doi: 10.1016/j.nuclcard.2024.102084.
PubMed Abstract available

TOUMA R, Njeim M, Jebara V, Abidov A, et al
Cardiac PET and CMR in Diagnosis of Epi-pericardial Fat Necrosis Associated with Severe Refractory Chest Pain Following Arrhythmia Ablation.
J Nucl Cardiol. 2024 Nov 15:102086. doi: 10.1016/j.nuclcard.2024.102086.
PubMed

TASAKA T, Ogimoto A, Saito M, Koike S, et al
Assessing the effectiveness of tafamidis therapy in patients with transthyretin cardiac amyloidosis using (99m)technetium pyrophosphate cardiac imaging.
J Nucl Cardiol. 2024 Nov 8:102075. doi: 10.1016/j.nuclcard.2024.102075.
PubMed

SATHYAMURTHI B, Sarish S, Khan MA, Arumugam P, et al
Benefit of 82-Rubidium Positron Emission Tomography for risk stratification in a patient with Intrapericardial diaphragmatic hernia.
J Nucl Cardiol. 2024 Nov 7:102070. doi: 10.1016/j.nuclcard.2024.102070.
PubMed

BUILOFF V, Huang C, Kuronuma K, Wei CC, et al
Automatic motion correction for myocardial blood flow estimation improves diagnostic performance for coronary artery disease in (18)F-flurpiridaz PET-MPI.
J Nucl Cardiol. 2024 Nov 5:102072. doi: 10.1016/j.nuclcard.2024.102072.
PubMed Abstract available

ZHANG X, Yang Y, Pretorius PH, Slomka PJ, et al
Cardiac motion correction with a deep learning network for perfusion defect assessment in SPECT myocardial perfusion imaging.
J Nucl Cardiol. 2024 Nov 2:102071. doi: 10.1016/j.nuclcard.2024.102071.
PubMed Abstract available

GAO D, Aykac M, Hayden C, Beanlands R, et al
Rubidium-82 Dose Effects on Myocardial Blood Flow Measurements using a Digital PET-CT Scanner.
J Nucl Cardiol. 2024 Nov 1:102073. doi: 10.1016/j.nuclcard.2024.102073.
PubMed

MURTHY VL
Dawn of the cardiac PET era.
J Nucl Cardiol. 2024;41:102055.
PubMed

October 2024

ROZANSKI A, Gransar H, Miller RJ, Han D, et al
Clinical Correlates of a Single-item Physical Activity Questionnaire among Patients Undergoing Stress SPECT Myocardial Perfusion Imaging.
J Nucl Cardiol. 2024 Oct 30:102066. doi: 10.1016/j.nuclcard.2024.102066.
PubMed Abstract available

KURONUMA K, Rozanski A, Han D, Park R, et al
Use of a Single-item Exercise Questionnaire Predicts Prognostic Risk among Patients undergoing Stress PET-MPI.
J Nucl Cardiol. 2024 Oct 24:102065. doi: 10.1016/j.nuclcard.2024.102065.
PubMed Abstract available

KAMEL Y, Terrone D, Pelletier-Galarneau M
Caseous Calcification as a Cause of False Positive FDG-PET/CT in Native Valve Endocarditis.
J Nucl Cardiol. 2024 Oct 17:102058. doi: 10.1016/j.nuclcard.2024.102058.
PubMed

BOBER RM, Milani RV, Abelhad N, Velasco-Gonzalez C, et al
Fast vs slow rubidium-82 infusion profiles and test-retest precision of myocardial perfusion using contemporary 3D cardiac analog PET-CT imaging.
J Nucl Cardiol. 2024 Oct 17:102059. doi: 10.1016/j.nuclcard.2024.102059.
PubMed Abstract available

GODOY-RIVAS C, Elsadany M, Jaiswal A, Weissler-Snir A, et al
SPECT/CT Quantification of 99m-TC PYP Uptake to Assess Tafamidis Treatment Response in ATTR Cardiac Amyloidosis.
J Nucl Cardiol. 2024 Oct 8:102056. doi: 10.1016/j.nuclcard.2024.102056.
PubMed Abstract available

ROQUE A, Pizzi MN
Infection vs inflammation in prosthetic heart valves by [(18)F]FDG-PET/CT: a practical tutorial for accurate interpretation.
J Nucl Cardiol. 2024 Oct 4:102053. doi: 10.1016/j.nuclcard.2024.102053.
PubMed

POITRASSON-RIVIERE A, Vanderver MD, Hagio T, Arida-Moody L, et al
Automated Deep Learning Segmentation of Cardiac Inflammatory FDG PET.
J Nucl Cardiol. 2024 Oct 3:102052. doi: 10.1016/j.nuclcard.2024.102052.
PubMed Abstract available

DI CARLI MF
Re-imagining risk stratification in high-risk patients: PET and SPECT myocardial perfusion imaging in focus.
J Nucl Cardiol. 2024;40:102057.
PubMed

LIGA R, Giorgetti A, Bertasi M, Filidei E, et al
Myocardial ischemia in patients with mild-to-moderate aortic stenosis: Interaction with cardiac remodeling and adverse events.
J Nucl Cardiol. 2024;40:102017.
PubMed Abstract available

HAGE FG, Bourque JM, Pandey S, Shah NR, et al
American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imaging.
J Nucl Cardiol. 2024;40:102041.
PubMed Abstract available

September 2024

HASHIMOTO H, Kuronuma K, Hyun MC, Han D, et al
Head-to-head comparison of (18)F-sodium fluoride coronary PET imaging between a silicon photomultiplier with digital photon counting and conventional scanners.
J Nucl Cardiol. 2024 Sep 27:102045. doi: 10.1016/j.nuclcard.2024.102045.
PubMed Abstract available

SUAREZ JP, Dominguez ML, Vigil C, Fernandez B, et al
Detection of small vegetations in native bi-valvular (aortic + mitral) infective endocarditis with 4D ECG-gated cardiac [(18)F]FDG PET/CT.
J Nucl Cardiol. 2024 Sep 19:102043. doi: 10.1016/j.nuclcard.2024.102043.
PubMed

AUER B
Parametric (82)Rb-Chloride PET Imaging of Myocardial Blood Flow: Ready for Clinical Prime Time?
J Nucl Cardiol. 2024 Sep 14:102040. doi: 10.1016/j.nuclcard.2024.102040.
PubMed

ROZANSKI A, Berman D
Evaluating the Prognostic Effectiveness of Stress SPECT versus PET Myocardial Perfusion Imaging.
J Nucl Cardiol. 2024 Sep 12:102038. doi: 10.1016/j.nuclcard.2024.102038.
PubMed

JOHNSON NP, Gould KL
How to differentiate obstructive from non-obstructive CAD with quantitative PET MPI using Coronary Flow Capacity.
J Nucl Cardiol. 2024 Sep 10:102039. doi: 10.1016/j.nuclcard.2024.102039.
PubMed

DI CARLI MF
Caravan of dreams: Precision quantitative imaging shaping the future of nuclear cardiology.
J Nucl Cardiol. 2024;39:102044.
PubMed

TRAVIN MI
Enhancing the utility of radionuclide adrenergic imaging for assessing the risk of sudden arrhythmic cardiac death.
J Nucl Cardiol. 2024;39:102022.
PubMed

VIJAYAKUMAR S, Pabon AR, Clerc OF, Cuddy SAM, et al
Quantitative (99m)Tc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy.
J Nucl Cardiol. 2024;39:102019.
PubMed Abstract available

August 2024

KAUR S, Chamseddine F, Abadie B, Sunder V, et al
Regional Variation in Technetium Pyrophosphate (PYP) Uptake in Transthyretin Cardiac Amyloidosis (ATTR-CA) and Concomitant Myocardial Infarction: A Case Series.
J Nucl Cardiol. 2024 Aug 29:102031. doi: 10.1016/j.nuclcard.2024.102031.
PubMed

AL-MALLAH M, Alwan M, Al Rifai M, Sayed A, et al
Cardiac Positron Emission Tomography and Other Modalities for CAD Assessment: A Snapshot from the Medicare Data.
J Nucl Cardiol. 2024 Aug 27:102030. doi: 10.1016/j.nuclcard.2024.102030.
PubMed Abstract available

PIZZI MN
Does digital PET/CT represent a step forward in the diagnostic accuracy of infective endocarditis?
J Nucl Cardiol. 2024 Aug 23:102024. doi: 10.1016/j.nuclcard.2024.102024.
PubMed

LEE JC, Chong JW, Hector BM
Communication of unexpected nuclear medicine and PET findings is a two-way street.
J Nucl Cardiol. 2024 Aug 15:102018. doi: 10.1016/j.nuclcard.2024.102018.
PubMed

HUNTER C, Moulton E, Beanlands R, deKemp R, et al
Parametric Imaging of Myocardial Blood Flow with (82)Rb PET: An Accuracy and Image Quality Analysis.
J Nucl Cardiol. 2024 Aug 10:102020. doi: 10.1016/j.nuclcard.2024.102020.
PubMed Abstract available

DI CARLI MF
Targeted molecular imaging of myocardial infarction: One more step in the right direction.
J Nucl Cardiol. 2024;38:102021.
PubMed

LU MT, Tawakol A
Deeper insights from deep learning: Enhanced myocardial perfusion assessments using multimodal artificial intelligence.
J Nucl Cardiol. 2024;38:102014.
PubMed

PELLETIER-GALARNEAU M
Liver failure and myocardial perfusion imaging: Wake up and smell the coffee.
J Nucl Cardiol. 2024;38:101904.
PubMed

AL-MALLAH MH, Al Rifai M, Saad JM
The role of splenic switch-off in assessing vasodilator response: When less is more.
J Nucl Cardiol. 2024;38:101896.
PubMed

KITKUNGVAN D, Johnson NP, Roby AE, Mendoza P, et al
Quantitative myocardial perfusion in liver transplantation candidates: Poorly metabolized caffeine inhibition of vasodilatory stress.
J Nucl Cardiol. 2024;38:101884.
PubMed Abstract available

July 2024

NOTOHAMIPRODJO S, Scheidhauer K, Eiber M, Yakushev I, et al
Impact of a dedicated cardiac protocol on diagnosis of infective endocarditis in patients undergoing [(18)F]-FDG-thoracic digital-PET/CT - Effects of expertise level.
J Nucl Cardiol. 2024 Jul 27:102010. doi: 10.1016/j.nuclcard.2024.102010.
PubMed Abstract available

DAHDAL J, Jukema RA, Harms HJ, Cramer MJ, et al
PET Myocardial Perfusion Imaging: Trends, Challenges, and Opportunities.
J Nucl Cardiol. 2024 Jul 25:102011. doi: 10.1016/j.nuclcard.2024.102011.
PubMed Abstract available

ALI A, Lu Y, Khalaf S, Iliescu C, et al
Use of Positron Emission Tomography for The Diagnosis of Immune Checkpoint Inhibitor Myocarditis.
J Nucl Cardiol. 2024 Jul 23:101909. doi: 10.1016/j.nuclcard.2024.101909.
PubMed

HUA C, Xi XY, Zhang Y, Suo N, et al
(99m)Tc-HFAPi SPECT Imaging Predicts Left Ventricular Remodeling After Acute Myocardial Infarction.
J Nucl Cardiol. 2024 Jul 13:101910. doi: 10.1016/j.nuclcard.2024.101910.
PubMed Abstract available

HAGEN JM, Zacherl MJ, Brendel M, Clauss S, et al
Quantitative assessment of cardiac (123)iodo-metaiodobenzylguanidine SPECT/CT in patients with arrhythmogenic right ventricular cardiomyopathy: novel insight in disease monitoring.
J Nucl Cardiol. 2024 Jul 13:101911. doi: 10.1016/j.nuclcard.2024.101911.
PubMed Abstract available

HUCK DM, Divakaran S, Weber B, Brown JM, et al
COMPARATIVE EFFECTIVENESS OF PET AND SPECT MPI FOR PREDICTING RISK IN PATIENTS WITH CARDIOMETABOLIC DISEASE.
J Nucl Cardiol. 2024 Jul 10:101908. doi: 10.1016/j.nuclcard.2024.101908.
PubMed Abstract available

SHETTY M, Bullock-Palmer RP, Dorbala S, Chareonthaitawee P, et al
#WINning together: Celebrating American Society of Nuclear Cardiology's women in nuclear cardiology initiative.
J Nucl Cardiol. 2024;37:101905.
PubMed

SOMAN P, Hyafil F
Resting myocardial blood flow: To correct, or not to correct, that is the question!
J Nucl Cardiol. 2024;37:101902.
PubMed

DI CARLI MF
July signals change: Welcoming new editorial voices and key clinical insights.
J Nucl Cardiol. 2024;37:101906.
PubMed

MAANIITTY T, Knuuti J
The additional value of relative assessment of quantitative myocardial blood flow.
J Nucl Cardiol. 2024;37:101886.
PubMed

CHIH S, Tavoosi A, Beanlands RSB
How to use nuclear cardiology to evaluate cardiac allograft vasculopathy.
J Nucl Cardiol. 2024;37:101866.
PubMed

HUCK DM, Weber BN, Brown JM, Lopez D, et al
Prognostic value of myocardial flow reserve vs corrected myocardial flow reserve in patients without obstructive coronary artery disease.
J Nucl Cardiol. 2024;37:101854.
PubMed Abstract available

June 2024

TEUHO J, Schultz J, Klen R, Juarez-Orozco LE, et al
Explainable deep learning-based ischemia detection using hybrid O-15 H2O perfusion PET/CT imaging and clinical data.
J Nucl Cardiol. 2024 Jun 7:101889. doi: 10.1016/j.nuclcard.2024.101889.
PubMed Abstract available

SELVARAJ S, Bravo PE
How to Prepare a Patient for FDG PET Imaging to Assess Myocardial Inflammation.
J Nucl Cardiol. 2024 Jun 1:101888. doi: 10.1016/j.nuclcard.2024.101888.
PubMed

DI CARLI MF
Charting the future of nuclear cardiology: Innovation, creativity, and perseverance.
J Nucl Cardiol. 2024;36:101890.
PubMed

KERR N, Miller RJH, Chew DS
Can nuclear cardiology optimize cardiac resynchronization therapy lead placement: Paving the way to precision medicine?
J Nucl Cardiol. 2024;36:101873.
PubMed

LIM P, Agarwal V, Patel KK
How to assess nonresponsiveness to vasodilator stress.
J Nucl Cardiol. 2024;36:101850.
PubMed Abstract available

May 2024

JUAREZ-OROZCO LE
Exploring PET-derived geometric indexes in ischemic heart disease - Is more in store?
J Nucl Cardiol. 2024 May 15:101883. doi: 10.1016/j.nuclcard.2024.101883.
PubMed

ROQUE A, Pizzi MN
PET/CT in aortic grafts: sufficient evidence or still leap of faith?
J Nucl Cardiol. 2024 May 9:101882. doi: 10.1016/j.nuclcard.2024.101882.
PubMed

MANABE O, Tamaki N
Revealing the Hidden Depths of Takotsubo Syndrome: The Crucial Role of PET in Understanding and Managing Cardiac Microvascular Dysfunction.
J Nucl Cardiol. 2024 May 7:101878. doi: 10.1016/j.nuclcard.2024.101878.
PubMed

ZHANG Y, Bos E, Clarkin O, Wilson T, et al
Interpretation of SPECT Wall Motion with Deep Learning.
J Nucl Cardiol. 2024 May 7:101881. doi: 10.1016/j.nuclcard.2024.101881.
PubMed Abstract available

MARK PD, Prescott E, Marner L, Hovind P, et al
[(15)O]H(2)O myocardial perfusion PET: Added value of relative stress perfusion deficit in the prediction of significant coronary artery stenosis in a mixed population.
J Nucl Cardiol. 2024 May 4:101880. doi: 10.1016/j.nuclcard.2024.101880.
PubMed Abstract available

DECORADS CE, Lambert A, Roch V, Imbert L, et al
Association between baseline hemodynamic indices, cardiotoxicity risk, and survival in women with breast cancer.
J Nucl Cardiol. 2024;35:101849.
PubMed Abstract available

April 2024

SI H, He Z, Malhotra S, Zhang X, et al
A novel method combining gated SPECT and vectorcardiography to guide left ventricular lead placement to improve response to cardiac resynchronization therapy: A Proof of Concept study.
J Nucl Cardiol. 2024 Apr 30:101867. doi: 10.1016/j.nuclcard.2024.101867.
PubMed Abstract available

BRORSON J, Gormsen LC, Madsen S, Tolbod LP, et al
Splenic switch-off in [(15)O]H(2)O-PET myocardial perfusion imaging using parametric blood flow images.
J Nucl Cardiol. 2024 Apr 27:101868. doi: 10.1016/j.nuclcard.2024.101868.
PubMed Abstract available

KADOYA Y, Chong AY, Small GR, Chow B, et al
Myocardial flow reserve recovery in patients with Takotsubo syndrome: insights from positron emission tomography.
J Nucl Cardiol. 2024 Apr 27:101869. doi: 10.1016/j.nuclcard.2024.101869.
PubMed Abstract available

HASSE B, Ledergerber B, Van Hemelrijck M, Frank M, et al
FDG uptake patterns in PET/CT caused by inflammation and/or infection after graft surgery for thoracic aortic dissection.
J Nucl Cardiol. 2024 Apr 26:101865. doi: 10.1016/j.nuclcard.2024.101865.
PubMed Abstract available

MARTINEZ-LUCIO TS, Alexanderson-Rosas E, Carvajal-Juarez I, Mendoza-Ibanez AK, et al
Left ventricular shape index and eccentricity index with ECG-gated Nitrogen-13 ammonia PET/CT in patients with myocardial infarction, ischemia and normal perfusion.
J Nucl Cardiol. 2024 Apr 10:101862. doi: 10.1016/j.nuclcard.2024.101862.
PubMed Abstract available

SPERRY BW, Vuppala S
Sequential FDG PET Imaging in Cardiac Sarcoidosis.
J Nucl Cardiol. 2024 Apr 5:101860. doi: 10.1016/j.nuclcard.2024.101860.
PubMed

March 2024

TAVOOSI A, Paquin A, deKemp R, Chong AY, et al
POSITRON EMISSION TOMOGRAPHY ASSESSMENT OF CORONARY MICROVASCULAR ANGINA IN PATIENTS WITH ANGINA AND NONOBSTRUCTIVE CORONARY ARTERY DISEASE.
J Nucl Cardiol. 2024 Mar 25:101853. doi: 10.1016/j.nuclcard.2024.101853.
PubMed

ABU-QAMAR O, Biery DW, Mendonca LSM, Barrett L, et al
Association between Abnormal Retinal Perfusion Indices by Optical Coherence Tomography Angiography and Myocardial Flow Reserve by PET/CT.
J Nucl Cardiol. 2024 Mar 25:101852. doi: 10.1016/j.nuclcard.2024.101852.
PubMed

BALMFORTH C, Whittington B, Tzolos E, Bing R, et al
Translational Molecular imaging: Thrombosis Imaging with Positron Emission Tomography.
J Nucl Cardiol. 2024 Mar 16:101848. doi: 10.1016/j.nuclcard.2024.101848.
PubMed Abstract available

KWIECINSKI J
Role of (18)F-sodium fluoride positron emission tomography in imaging atherosclerosis.
J Nucl Cardiol. 2024 Mar 11:101845. doi: 10.1016/j.nuclcard.2024.101845.
PubMed Abstract available

OKAFOR J, Khattar R, Kouranos V, Ohri S, et al
Role of serial (18)FDG-PET in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis.
J Nucl Cardiol. 2024 Mar 11:101842. doi: 10.1016/j.nuclcard.2024.101842.
PubMed Abstract available

RUDDY TD, Wells RG
Shortening the Acquisition Times of CZT SPECT Imaging for Measurement of Myocardial Blood Flow.
J Nucl Cardiol. 2024 Mar 9:101847. doi: 10.1016/j.nuclcard.2024.101847.
PubMed

DI CARLI MF
How is PET/CT Imaging Revolutionizing Cardiac Care: Let me Count the Ways.
J Nucl Cardiol. 2024 Mar 7:101844. doi: 10.1016/j.nuclcard.2024.101844.
PubMed Abstract available

PATEL KK, Singh A, Qarajeh R, Shatla I, et al
Prevalence of Balanced Ischemia on PET Relative Perfusion Imaging Among Patients with High-Risk Coronary Artery Disease.
J Nucl Cardiol. 2024 Mar 2:101836. doi: 10.1016/j.nuclcard.2024.101836.
PubMed

BOBER RM, Johnson NP
How might coronary sinus reducer treatment change myocardial perfusion?
J Nucl Cardiol. 2024;33:101828.
PubMed

AL RIFAI M, Winchester D
When should myocardial perfusion imaging be a first-test choice?
J Nucl Cardiol. 2024;33:101824.
PubMed

ZAMPELLA E, Assante R, Acampa W
A good assist is followed by a goal.
J Nucl Cardiol. 2024;33:101807.
PubMed

AKSIT E, Kirilmaz B, Ozdemir S
The importance of myocardial perfusion imaging in patients with ischemia and nonobstructive coronary arteries.
J Nucl Cardiol. 2024;33:101791.
PubMed

February 2024

SOLANKI R, Singh H, Mehta V, Panda P, et al
Potential application of (68)Ga-FAPI PET/CT for diagnosing cardiac sarcoidosis.
J Nucl Cardiol. 2024 Feb 23:101835. doi: 10.1016/j.nuclcard.2024.101835.
PubMed

SEVAG PACKARD RR
Expanding the Repertoire of (18)F-Labeled PET MPI Radiotracers.
J Nucl Cardiol. 2024 Feb 23:101834. doi: 10.1016/j.nuclcard.2024.101834.
PubMed

LIU A, Cain L, Munemo LT, Ahmed R, et al
Characterisation and management of expected and unexpected urgent findings from FDG-PET-CT in cardiovascular disease.
J Nucl Cardiol. 2024 Feb 20:101826. doi: 10.1016/j.nuclcard.2024.101826.
PubMed Abstract available

WANG J, Chen Y, Chu H, Pang Z, et al
Feasibility of Myocardial Blood Flow Quantification to Detect Flow-limited Coronary Artery Disease with A One-day Rest/Stress Continuous Rapid Imaging Protocol on Cardiac-dedicated CZT SPECT.
J Nucl Cardiol. 2024 Feb 20:101825. doi: 10.1016/j.nuclcard.2024.101825.
PubMed Abstract available

REN C, Pan Q, Fu C, Wang P, et al
Phase I, first-in-human study of XTR004, a novel (18)F-labeled tracer for myocardial perfusion PET: biodistribution, radiation dosimetry, pharmacokinetics and safety after a single injection at rest.
J Nucl Cardiol. 2024 Feb 13:101823. doi: 10.1016/j.nuclcard.2024.101823.
PubMed Abstract available

BOURQUE JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, et al
(18)F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I(2)) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM
J Nucl Cardiol. 2024 Feb 12:101786. doi: 10.1016/j.nuclcard.2023.101786.
PubMed Abstract available

DI CARLI MF
Navigating the positron emission tomography vs. single-photon emission computed tomography debate: A closer look at evidence and guidelines.
J Nucl Cardiol. 2024 Feb 2:101822. doi: 10.1016/j.nuclcard.2024.101822.
PubMed

January 2024

BHATTARU A, Rojulpote C, Vidula M, Duda J, et al
Deep Learning Approach for Automated Segmentation of Myocardium Using Bone Scintigraphy SPECT/CT in Patients with Suspected Cardiac Amyloidosis.
J Nucl Cardiol. 2024 Jan 31:101809. doi: 10.1016/j.nuclcard.2024.101809.
PubMed Abstract available

HAN Y, Ahmed AI, Saad JM, Alahdab F, et al
Ejection Fraction And Ventricular Volumes On Rubidium Positron Emission Tomography: Prospective Validation Against Cardiovascular Magnetic Resonance.
J Nucl Cardiol. 2024 Jan 27:101810. doi: 10.1016/j.nuclcard.2024.101810.
PubMed Abstract available

FUJIOKA K, Norikane T, Takami Y, Yamamoto Y, et al
Feasibility of PiB PET/CT for treatment monitoring with Tafamidis in a patient with ATTR-CA.
J Nucl Cardiol. 2024 Jan 19:101816. doi: 10.1016/j.nuclcard.2024.101816.
PubMed

DIETZ M, Bochaton T, Al Mansour L, Tordo J, et al
Identification of lipomatous metaplasia on CT images helps confirm prior silent myocardial infarction associated with equivocal perfusion abnormality on SPECT/CT imaging.
J Nucl Cardiol. 2024 Jan 19:101812. doi: 10.1016/j.nuclcard.2024.101812.
PubMed

WILLIAMS MC
Machine learning models for PET myocardial perfusion imaging.
J Nucl Cardiol. 2024 Jan 18:101805. doi: 10.1016/j.nuclcard.2024.101805.
PubMed

ROZANSKI A, Miller RJH, Han D, Gransar H, et al
Comparative Predictors of Mortality among Patients Referred for Stress SPECT versus PET Myocardial Perfusion Imaging.
J Nucl Cardiol. 2024 Jan 18:101811. doi: 10.1016/j.nuclcard.2024.101811.
PubMed Abstract available

CHENG K, Tan ST, Wechalekar K, Keramida G, et al
Redistribution of myocardial perfusion after coronary sinus reducer implantation demonstrated by rubidium-82 positron emission tomography.
J Nucl Cardiol. 2024 Jan 12:101803. doi: 10.1016/j.nuclcard.2024.101803.
PubMed

SANGHANI R, Al-Mallah MH, Thompson R
Challenges and Strategies to enable access to Cardiac PET in Different Parts of the World: The North American Perspective.
J Nucl Cardiol. 2024 Jan 10:101790. doi: 10.1016/j.nuclcard.2023.101790.
PubMed

BORGES-ROSA J, Oliveira-Santos M, Silva R, Elvas L, et al
(18)F-FDG PET-CT FOR DIAGNOSING CUTANEOUS FISTULAS SECONDARY TO RETAINED LEAD FRAGMENTS: A RARE AND CHALLENGING COMPLICATION AFTER PACEMAKER EXTRACTION.
J Nucl Cardiol. 2024 Jan 6:101794. doi: 10.1016/j.nuclcard.2024.101794.
PubMed

BAILLY M, Gamet A, Metrard G
Potential utility of myocardial blood flow quantification with SPECT in a patient undergoing treatment for breast cancer.
J Nucl Cardiol. 2024 Jan 5:101799. doi: 10.1016/j.nuclcard.2024.101799.
PubMed

FUJIOKA K, Norikane T, Takami Y, Yamamoto Y, et al
Feasibility of PiB PET/CT for treatment monitoring with Tafamidis in a patient with ATTR-CA.
J Nucl Cardiol. 2024 Jan 5:101800. doi: 10.1016/j.nuclcard.2024.101800.
PubMed

BERMAN D, Hunter C, Hossain A, Yao J, et al
Machine and deep learning models for accurate detection of ischemia and scar with myocardial blood flow PET imaging.
J Nucl Cardiol. 2024 Jan 5:101797. doi: 10.1016/j.nuclcard.2024.101797.
PubMed Abstract available

GAEMPERLI O
Ejection fraction and ventricular volumes on Rb PET: Validation against cardiovascular MRI.
J Nucl Cardiol. 2024 Jan 4:101795. doi: 10.1016/j.nuclcard.2024.101795.
PubMed

HOFF CM, Sorensen J, Kero T, Bouchelouche K, et al
Quantitative and qualitative comparison of Rubidium-82 and Oxygen-15 water cardiac PET.
J Nucl Cardiol. 2024 Jan 4:101796. doi: 10.1016/j.nuclcard.2024.101796.
PubMed Abstract available

ABAZID RM, Davey RA, Romsa J, Florendo-Cumbermack A, et al
Progressive development of cardiac amyloidosis in a hereditary transthyretin gene carrier on serial Tc-99m PYP SPECT-CT.
J Nucl Cardiol. 2024;31:101774.
PubMed

CROWLEY A, Gerson M
The future of PET imaging: Looking forward to more choices and increased precision with the use of oxygen-15 water.
J Nucl Cardiol. 2024;31:101775.
PubMed

SUERO-ABREU GA, Lim P, Raza A, Tysarowski M, et al
Effect of variable left ventricular ejection fraction assessed by equilibrium radionuclide angiocardiography using different software packages on the diagnosis of cardiotoxicity in patients with cancer.
J Nucl Cardiol. 2024;31:101782.
PubMed Abstract available

DI CARLI MF, Gormsen LC, Chareonthaitawee P, Johnson GB, et al
Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW.
J Nucl Cardiol. 2024;31:101779.
PubMed Abstract available

December 2023

ARUMUGAM P, Better N, Keng FY, Allam A, et al
Current state and challenges of implementing a cardiac positron emission tomography program outside North America.
J Nucl Cardiol. 2023;31:101788.
PubMed

DANAD I, Driessen RS
Utility of (82)Rb and [(15)O]H(2)O PET myocardial perfusion imaging in challenging (high risk) patients: "Don't throw the baby out with the bathwater".
J Nucl Cardiol. 2023 Dec 2:101783. doi: 10.1016/j.nuclcard.2023.101783.
PubMed

HUDSON O, Hage FG
Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.
J Nucl Cardiol. 2023;30:2615-2617.
PubMed

ROZANSKI A, Gransar H, Sakul S, Miller RJH, et al
Increasing frequency of dyspnea among patients referred for cardiac stress testing.
J Nucl Cardiol. 2023;30:2303-2313.
PubMed Abstract available

AL-MALLAH MH
ASNC without borders: A global effort in nuclear cardiology.
J Nucl Cardiol. 2023;30:2972-2975.
PubMed

NAKAJIMA K, Shibutani T, Massanes F, Shimizu T, et al
Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia.
J Nucl Cardiol. 2023;30:2773-2789.
PubMed Abstract available

LI L, Gao J, Chen BX, Liu X, et al
Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study.
J Nucl Cardiol. 2023;30:2712-2720.
PubMed Abstract available

MATTHEWS B, Duddleston D, Hage FG
Myocardial perfusion imaging in congenitally corrected transposition of the great arteries.
J Nucl Cardiol. 2023;30:2907-2910.
PubMed

YU W, Yang L, Zhang F, Liu B, et al
Machine learning to predict hemodynamically significant CAD based on traditional risk factors, coronary artery calcium and epicardial fat volume.
J Nucl Cardiol. 2023;30:2593-2606.
PubMed Abstract available

LASSEN ML, Byrne C, Hartmann JP, Kjaer A, et al
Pulmonary blood volume assessment from a standard cardiac rubidium-82 imaging protocol: impact of adenosine-induced hyperemia.
J Nucl Cardiol. 2023;30:2504-2513.
PubMed Abstract available

SCIAGRA R, Linguanti F
The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.
J Nucl Cardiol. 2023;30:2346-2348.
PubMed Abstract available

REID BJ, Lindow T, Warren S, Persson E, et al
Immediate recruitment of dormant coronary collaterals can provide more than half of normal resting perfusion during coronary occlusion in patients with coronary artery disease.
J Nucl Cardiol. 2023;30:2338-2345.
PubMed Abstract available

PRETORIUS PH, Liu J, Kalluri KS, Jiang Y, et al
Observer studies of image quality of denoising reduced-count cardiac single photon emission computed tomography myocardial perfusion imaging by three-dimensional Gaussian post-reconstruction filtering and deep learning.
J Nucl Cardiol. 2023;30:2427-2437.
PubMed Abstract available

DAWDY J, Polina A, Abidov A
Ascites and liver cirrhosis diagnosed on cardiac scintigraphic imaging.
J Nucl Cardiol. 2023;30:2837-2838.
PubMed

MANNARINO T, D'Antonio A, Assante R, Zampella E, et al
Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say.
J Nucl Cardiol. 2023;30:2349-2360.
PubMed Abstract available

SUBRAMANIAN K, Mittal BR, Singh H, Sood A, et al
Stigmata of portal hypertension depicted on myocardial perfusion imaging.
J Nucl Cardiol. 2023;30:2813-2815.
PubMed

RAVAL M, Siddiq S
Extra-cardiac uptake of 99mTc-pyrophosphate scan leading to the diagnosis of stage IV metastatic prostatic adenocarcinoma.
J Nucl Cardiol. 2023;30:2807-2808.
PubMed

SUBRAMANIAN K, Mahdi R, Singh H, Sood A, et al
Perfusion defect with characteristic anterior wall indentation on myocardial perfusion imaging caused by a large left ventricular aneurysm.
J Nucl Cardiol. 2023;30:2809-2812.
PubMed

YAGHOOBI N, Maghsudi M, Malek H, Bakhshandeh H, et al
Role of CT attenuation correction gated SPECT MPI in prediction of pulmonary hypertension.
J Nucl Cardiol. 2023;31:101777.
PubMed Abstract available

MATTHEWS B, Duddleston D, Hage FG
Myocardial perfusion imaging in congenitally corrected transposition of the great arteries.
J Nucl Cardiol. 2023;30:2907-2910.
PubMed

BUTT F, Siegel A
Acute intramural hematoma of the ascending aorta discovered on myocardial perfusion SPECT.
J Nucl Cardiol. 2023;30:2841-2843.
PubMed

SILLANMAKI S, Iso-Mustajarvi S
(18)F-FDG-PET of cardiac sarcoidosis with subcutaneous nodules.
J Nucl Cardiol. 2023;30:2839-2840.
PubMed

DAWDY J, Polina A, Abidov A
Ascites and liver cirrhosis diagnosed on cardiac scintigraphic imaging.
J Nucl Cardiol. 2023;30:2837-2838.
PubMed

SUBRAMANIAN K, Bahl A, Singh H, Singh H, et al
Invasive cardiac aspergillosis in an immuno-competent patient: distinctive imaging features on 18F-fluorodeoxyglucose (FDG)-PET/CT and 99mTc-sestamibi SPECT myocardial perfusion imaging.
J Nucl Cardiol. 2023;30:2825-2827.
PubMed

KAUR S, Bartley P, Gordon S, Higgins A, et al
Left ventricular assist device infection on (18)F-flourodeoxyglucose positron emission tomography.
J Nucl Cardiol. 2023;30:2823-2824.
PubMed Abstract available

YAMAMOTO A, Nagao M, Inai K, Shinkawa T, et al
Coronary microvascular dysfunction detected by (13)N-ammonia positron emission tomography in a patient with repaired aortic coarctation.
J Nucl Cardiol. 2023;30:2819-2822.
PubMed

SUBRAMANIAN K, Mittal BR, Singh H, Sood A, et al
Stigmata of portal hypertension depicted on myocardial perfusion imaging.
J Nucl Cardiol. 2023;30:2813-2815.
PubMed

RAVAL M, Siddiq S
Extra-cardiac uptake of 99mTc-pyrophosphate scan leading to the diagnosis of stage IV metastatic prostatic adenocarcinoma.
J Nucl Cardiol. 2023;30:2807-2808.
PubMed

FITCH JS, Schwartz RG
Detection and quantification of myocardial scar and LVEF with high efficiency digital SPECT: The expanding value proposition for clinical cardiology.
J Nucl Cardiol. 2023;30:2803-2806.
PubMed

KRAKAUER M, Ismail A, Talleruphuus U, Henriksen AC, et al
(82)Rb and [(15)O]H(2)O myocardial perfusion PET imaging: a prospective head to head comparison.
J Nucl Cardiol. 2023;30:2790-2802.
PubMed Abstract available

JAHANDIDEH A, Virta J, Li XG, Liljenback H, et al
Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.
J Nucl Cardiol. 2023;30:2760-2772.
PubMed Abstract available

JUAREZ-OROZCO LE, Niemi M, Yeung MW, Benjamins JW, et al
Hybridizing machine learning in survival analysis of cardiac PET/CT imaging.
J Nucl Cardiol. 2023;30:2750-2759.
PubMed Abstract available

CHRISTENSEN NL, Nordstrom J, Madsen S, Madsen MA, et al
Detection and correction of patient motion in dynamic (15)O-water PET MPI.
J Nucl Cardiol. 2023;30:2736-2749.
PubMed Abstract available

WATANABE S, Nakajima K, Toshima F, Wakabayashi H, et al
Transthyretin amyloid cardiomyopathy disease burden quantified using (99m)Tc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours.
J Nucl Cardiol. 2023;30:2721-2735.
PubMed Abstract available

LI L, Gao J, Chen BX, Liu X, et al
Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study.
J Nucl Cardiol. 2023;30:2712-2720.
PubMed Abstract available

DE OLIVEIRA RS, Moll-Bernardes R, de Brito AX, Pinheiro MVT, et al
Use of PET/CT to detect myocardial inflammation and the risk of malignant arrhythmia in chronic Chagas disease.
J Nucl Cardiol. 2023;30:2702-2711.
PubMed Abstract available

KAMERMAN M, van Dijk JD, Timmer JR, Ottervanger JP, et al
The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
J Nucl Cardiol. 2023;30:2692-2701.
PubMed Abstract available

ARNFIELD EG, Tam L, Pattison DA, Younger J, et al
Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.
J Nucl Cardiol. 2023;30:2676-2691.
PubMed Abstract available

SAN MIGUEL L, Goldschmidt E, Brisbin AK, Redruello M, et al
A new perspective on an old method: gated SPECT imaging for left ventricular contractile function assessment.
J Nucl Cardiol. 2023;30:2658-2665.
PubMed Abstract available

CAMONI L, Dondi F
Time-efficient cardiac imaging: early post-injection stress-first protocol myocardial perfusion SPECT with a CZT camera.
J Nucl Cardiol. 2023;30:2655-2657.
PubMed

CASE JA, Courter SA, McGhie A, Patel KK, et al
Accurate and efficient rapid acquisition early post-injection stress-first CZT SPECT myocardial perfusion imaging with tetrofosmin and attenuation correction.
J Nucl Cardiol. 2023;30:2644-2654.
PubMed Abstract available

GRAMBOW-VELILLA J, Mahida B, Benali K, Deconinck L, et al
Prognosis and follow-up of patients with prosthetic valve endocarditis treated conservatively in relation to WBC-SPECT imaging.
J Nucl Cardiol. 2023;30:2633-2643.
PubMed Abstract available

ZHANG J, Xie J, Li M, Fang W, et al
SPECT myocardial blood flow quantitation for the detection of angiographic stenoses with cardiac-dedicated CZT SPECT.
J Nucl Cardiol. 2023;30:2618-2632.
PubMed Abstract available

HUDSON O, Hage FG
Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.
J Nucl Cardiol. 2023;30:2615-2617.
PubMed

AKINCIOGLU C, Murthi M, Romsa J, Warrington J, et al
Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.
J Nucl Cardiol. 2023;30:2607-2614.
PubMed Abstract available

LI L, Pang Z, Wang J, Chen Y, et al
Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA.
J Nucl Cardiol. 2023;30:2578-2592.
PubMed Abstract available

CLERC OF, Frey SM, Honegger U, Amrein MLF, et al
Coronary artery calcium score and pre-test probabilities as gatekeepers to predict and rule out perfusion defects in positron emission tomography.
J Nucl Cardiol. 2023;30:2559-2573.
PubMed Abstract available

SAZONOVA SI, Ilyushenkova JN, Syrkina AG, Trusov AA, et al
Potential utility of SPECT/CT with 99mTc-Tektrotyd for imaging of post-myocardial infarction inflammation.
J Nucl Cardiol. 2023;30:2544-2555.
PubMed Abstract available

KHOR YM, Dorbala S
Extra-cardiac uptake on technetium-99m pyrophosphate (Tc-99m PYP) scan: not just a matter of the heart.
J Nucl Cardiol. 2023;30:2540-2543.
PubMed

KHERAJANI P, Farag AA, Morgan WS, Hage FG, et al
Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
J Nucl Cardiol. 2023;30:2525-2530.
PubMed Abstract available

ADHADUK M, Paudel B, Liu K, Ashwath M, et al
Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
J Nucl Cardiol. 2023;30:2514-2524.
PubMed Abstract available

JOHN LA, Tedrow UB, Divakaran S
Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
J Nucl Cardiol. 2023;30:2501-2503.
PubMed

LUCINIAN YA, Martineau P, Poenaru R, Tremblay-Gravel M, et al
FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
J Nucl Cardiol. 2023;30:2490-2500.
PubMed Abstract available

TAVOOSI A, Khetarpal R, Wells RG, Beanlands RSB, et al
Exponential dosing to standardize myocardial perfusion image quality with rubidium-82 PET.
J Nucl Cardiol. 2023;30:2477-2489.
PubMed Abstract available

AHLUWALIA N, Roshankar G, Draycott L, Jimenez-Zepeda V, et al
Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis.
J Nucl Cardiol. 2023;30:2464-2476.
PubMed Abstract available

CHAN SH, Huang CK, Luzhbin D, Hou PN, et al
Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT.
J Nucl Cardiol. 2023;30:2454-2463.
PubMed Abstract available

HANSEN CL
Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for "clean blood pool" imaging.
J Nucl Cardiol. 2023;30:2418-2426.
PubMed Abstract available

SAG SJM, Menhart K, Hitzenbichler F, Schmid C, et al
(18)F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center.
J Nucl Cardiol. 2023;30:2400-2414.
PubMed Abstract available

KITAGAWA T, Sasaki K, Fujii Y, Ikegami Y, et al
(18)F-sodium fluoride positron emission tomography following coronary computed tomography angiography in predicting long-term coronary events: a 5-year follow-up study.
J Nucl Cardiol. 2023;30:2365-2378.
PubMed Abstract available

SCIAGRA R, Linguanti F
The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.
J Nucl Cardiol. 2023;30:2346-2348.
PubMed Abstract available

PICCINELLI M, Cooke CD, Folks R, Garcia EV, et al
4D display of CT LV endocardial and epicardial models morphed from PET Rb-82 perfusion studies accurately quantifies segmental myocardial thickening.
J Nucl Cardiol. 2023;30:2314-2326.
PubMed Abstract available

LIMA BB, Benz DC
Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET.
J Nucl Cardiol. 2023;30:2301-2302.
PubMed

LASSEN ML, Rasmussen T, Byrne C, Holmvang L, et al
Myocardial creep and cardiorespiratory motion correction improves diagnostic accuracy of Rubidium-82 cardiac positron emission tomography.
J Nucl Cardiol. 2023;30:2289-2300.
PubMed Abstract available

BATEMAN TM
In 2023 PET myocardial perfusion imaging is preferred to invasive coronary angiography for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
J Nucl Cardiol. 2023;30:2273-2278.
PubMed

JOHNSRUD DO, Port SC
In 2023 invasive coronary angiography is preferred to PET myocardial perfusion imaging for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
J Nucl Cardiol. 2023;30:2269-2272.
PubMed

November 2023

KAMERMAN M, van Dijk JD, Timmer JR, Ottervanger JP, et al
Correction to: The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
J Nucl Cardiol. 2023 Nov 6. doi: 10.1007/s12350-023-03389.
PubMed

October 2023

CHAREONTHAITAWEE P, Bateman TM, Beanlands RS, Berman DS, et al
Atlas for reporting PET myocardial perfusion imaging and myocardial blood flow in clinical practice: an information statement from the American Society of Nuclear Cardiology.
J Nucl Cardiol. 2023 Oct 27. doi: 10.1007/s12350-023-03378.
PubMed

LOHARKAR S, Sonavane SN, Shah H, Basu S, et al
What is this image? 2023 Image 3 results: Cardiac tuberculosis presenting as cardiac mass: role of (18)F-FDG PET/CT in monitoring response to treatment.
J Nucl Cardiol. 2023 Oct 2. doi: 10.1007/s12350-023-03381.
PubMed

MAIR BA, Zelt JGE, Nekesa K, Saint-Georges Z, et al
Pharmacological and metabolic parameters of [(18)F]flubrobenguane in clinical imaging populations.
J Nucl Cardiol. 2023;30:2089-2095.
PubMed Abstract available

BULLOCK-PALMER RP
Utility of myocardial blood flow assessment with dynamic CZT single photon emission computed tomography in patients with myocardial bridging: Is this 'wishful thinking' in this dynamic situation?
J Nucl Cardiol. 2023;30:2068-2072.
PubMed

IBRAHIM J, Soman P
The past, present, and future of attenuation correction for myocardial perfusion imaging.
J Nucl Cardiol. 2023;30:1794-1796.
PubMed

TOTTLEBEN J, Torres A, Doukky R
Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation.
J Nucl Cardiol. 2023;30:1897-1903.
PubMed Abstract available

DAKIK HA, Ghazzal Z, Haidar M
Screening asymptomatic patients post PCI with myocardial perfusion imaging.
J Nucl Cardiol. 2023;30:2248-2251.
PubMed

NAYFEH M, Ahmed AI, Al-Mallah MH
Unveiling the hidden link: deciphering the interplay between plaque characteristics and nuclear myocardial perfusion imaging.
J Nucl Cardiol. 2023;30:1851-1855.
PubMed

HEDEER F, Akil S, Oddstig J, Hindorf C, et al
Diagnostic accuracy for CZT gamma camera compared to conventional gamma camera technique with myocardial perfusion single-photon emission computed tomography: Assessment of myocardial infarction and function.
J Nucl Cardiol. 2023;30:1935-1946.
PubMed Abstract available

AL TAHA Z, Alibazoglu D, Sabbour H, Romany I, et al
Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies.
J Nucl Cardiol. 2023;30:1922-1934.
PubMed Abstract available

WANG Y, Yu W, Yang X, Zhang F, et al
Left ventricular systolic dyssynchrony: a novel imaging marker for early assessment of myocardial damage in Chinese type 2 diabetes mellitus patients with normal left ventricular ejection fraction and normal myocardial perfusion.
J Nucl Cardiol. 2023;30:1797-1809.
PubMed Abstract available

VALZANIA C, Paccagnella A, Spadotto A, Ruotolo I, et al
Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.
J Nucl Cardiol. 2023;30:2104-2111.
PubMed Abstract available

ANDERSSON Y, Fernandez G, Mars P, Lindow T, et al
Significant myocardial perfusion defect during stress visible in prone but not in supine imaging.
J Nucl Cardiol. 2023;30:2209-2212.
PubMed

DORAN JA, Sajjad W, Schneider MD, Gupta R, et al
Retraction Note: Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
J Nucl Cardiol. 2023;30:2254.
PubMed

NIELSEN MO, Schledermann H, Jensen LT
Primary breast cancer diagnosed by 82-Rubidium myocardial perfusion PET-scan.
J Nucl Cardiol. 2023;30:2252-2253.
PubMed

DAKIK HA, Ghazzal Z, Haidar M
Screening asymptomatic patients post PCI with myocardial perfusion imaging.
J Nucl Cardiol. 2023;30:2248-2251.
PubMed

CHEN LQ, Nichols KJ, Van Tosh A
Exercise ECG must be considered in conjunction with conventional SPECT.
J Nucl Cardiol. 2023;30:2245-2247.
PubMed

SUTHERLAND N, Sivaratnam D, Pearson M, Better N, et al
Use of SPECT imaging to confirm ATTR cardiac amyloid in a Tc99m pyrophosphate study artefactually compromised by a recent V/Q scan.
J Nucl Cardiol. 2023;30:2242-2244.
PubMed

AIKAWA T, Manabe O, Ibe T, Oyama-Manabe N, et al
Serial assessment of cardiac involvement in sarcoidosis by delayed (18)F-fluorodeoxyglucose PET/CT.
J Nucl Cardiol. 2023;30:2225-2228.
PubMed

ZMAILI M, Jaber W
First experience of LVEF assessment with cardiac amyloid SPECT scan.
J Nucl Cardiol. 2023;30:2222-2224.
PubMed

TAKAHASHI K, Morioka H, Sasaki D, Yamamura N, et al
Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.
J Nucl Cardiol. 2023;30:2215-2221.
PubMed

JALEEL J, Patel C, Khangembam B, Kumar S, et al
Utility of 68Ga-DOTANOC PET/CT in therapeutic monitoring of cardiac sarcoidosis.
J Nucl Cardiol. 2023;30:2213-2214.
PubMed Abstract available

TAKAHASHI K, Sasaki D, Uemura S, Okura T, et al
(99m)Tc-PYP SPECT/CT as part of the diagnostic workup of left ventricular apical aneurysm in a patient with hypertrophic cardiomyopathy.
J Nucl Cardiol. 2023;30:2198-2203.
PubMed

QAMAR I, Grewal S, Fahed AC, Weiner R, et al
PET myocardial perfusion imaging of regadenoson-induced coronary vasospasm.
J Nucl Cardiol. 2023;30:2187-2190.
PubMed

DILSIZIAN V, Bacharach SL, Beanlands RS, Bergmann SR, et al
Correction to: ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.
J Nucl Cardiol. 2023;30:2186.
PubMed

HORGAN S, Sanghani R, Miller S, Al-Mallah M, et al
ASNC model coverage policy: 2023 cardiac positron emission tomography.
J Nucl Cardiol. 2023;30:2114-2185.
PubMed

BUCY L, Erpelding ML, Boursier C, Lefevre B, et al
Real world experience of therapeutic monitoring of medically treated prosthetic valve infective endocarditis by (18)F-FDG-PET/CT.
J Nucl Cardiol. 2023;30:2096-2103.
PubMed Abstract available

BENTSEN S, Jensen JK, Christensen E, Petersen LR, et al
[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure.
J Nucl Cardiol. 2023;30:2073-2084.
PubMed Abstract available

XU R, Yang H, Zhang J, Chen S, et al
Dynamic perfusion SPECT for functional evaluation in symptomatic patients with myocardial bridging.
J Nucl Cardiol. 2023;30:2058-2067.
PubMed Abstract available

PETRETTA M, Panico M, Mainolfi CG, Cuocolo A, et al
Including myocardial flow reserve by PET in prediction models: Ready to fly?
J Nucl Cardiol. 2023;30:2054-2057.
PubMed

MIURA S, Okizaki A, Kumamaru H, Manabe O, et al
Interaction of impaired myocardial flow reserve and extent of myocardial ischemia assessed using (13)N-ammonia positron emission tomography imaging on adverse cardiovascular outcomes.
J Nucl Cardiol. 2023;30:2043-2053.
PubMed Abstract available

HULTEN E, Keating FK
Diagnosis of diffuse ischemia with SPECT relative perfusion imaging: How to eat soup with a fork?
J Nucl Cardiol. 2023;30:2039-2042.
PubMed

KUPUSOVIC J, Kessler L, Bruns F, Bohnen JE, et al
Visualization of fibroblast activation using (68)Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation.
J Nucl Cardiol. 2023;30:2018-2028.
PubMed Abstract available

MALLET F, Poitrasson-Riviere A, Mariano-Goulart D, Agostini D, et al
Measuring myocardial blood flow using dynamic myocardial perfusion SPECT: artifacts and pitfalls.
J Nucl Cardiol. 2023;30:2006-2017.
PubMed Abstract available

DAI N, Zhang B, Gong Z, Dong Z, et al
Quantitative flow ratio derived pullback pressure gradient and CZT-SPECT measured longitudinal flow gradient for hemodynamically significant coronary artery disease.
J Nucl Cardiol. 2023;30:1992-2002.
PubMed Abstract available

WANG A, Mahmood U, Tang X, Jain D, et al
A case of disappearing amyloid on technetium pyrophosphate scan.
J Nucl Cardiol. 2023;30:1986-1991.
PubMed Abstract available

TANG X, Dai N, Zhang B, Cai H, et al
Comparison of 2D-QCA, 3D-QCA and coronary angiography derived FFR in predicting myocardial ischemia assessed by CZT-SPECT MPI.
J Nucl Cardiol. 2023;30:1973-1982.
PubMed Abstract available

NAKAJIMA K, Shibutani T
Are nuclear medicine images quantified in 2D and 3D equally functional?
J Nucl Cardiol. 2023;30:1968-1972.
PubMed

IMOTO A, Tateishi E, Murakawa K, Ohta Y, et al
Lung-to-heart ratio analysis using virtual planar images obtained from myocardial perfusion SPECT data: A phantom and clinical studies.
J Nucl Cardiol. 2023;30:1959-1967.
PubMed Abstract available

FUKUSHIMA K, Endo K, Yamakuni R, Kiko T, et al
Simultaneous assessment of left ventricular mechanical dyssynchrony using integrated (13)N-ammonia PETMR system: direct comparison of PET phase analysis and MR feature tracking.
J Nucl Cardiol. 2023;30:1947-1958.
PubMed Abstract available

QUTBI M
Adjustment of acquisition arc in cardiac malposition during myocardial perfusion SPECT imaging: computer simulation based on deterministic modeling.
J Nucl Cardiol. 2023;30:1910-1921.
PubMed Abstract available

KOENDERS SS, van Dalen JA, Jager PL, Mouden M, et al
Patient-tailored risk assessment of obstructive coronary artery disease using Rubidium-82 PET-based myocardial flow quantification with visual interpretation.
J Nucl Cardiol. 2023;30:1890-1896.
PubMed Abstract available

HANAOKA K, Watanabe S, Morimoto-Ishikawa D, Kaida H, et al
Impact of respiratory gating and ECG gating on (18)F-FDG PET/CT for cardiac sarcoidosis.
J Nucl Cardiol. 2023;30:1879-1885.
PubMed Abstract available

CHEN X, Liu C
Deep-learning-based methods of attenuation correction for SPECT and PET.
J Nucl Cardiol. 2023;30:1859-1878.
PubMed Abstract available

HIJAZI W, Miller RJH
Deep learning to automate SPECT MPI myocardial reorientation.
J Nucl Cardiol. 2023;30:1836-1837.
PubMed

ZHU F, Wang G, Zhao C, Malhotra S, et al
Automatic reorientation by deep learning to generate short-axis SPECT myocardial perfusion images.
J Nucl Cardiol. 2023;30:1825-1835.
PubMed Abstract available

GATTERER C, Wollenweber T, Pichler V, Vraka C, et al
Detection of sympathetic denervation defects in Fabry disease by hybrid [(11)C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance.
J Nucl Cardiol. 2023;30:1810-1821.
PubMed Abstract available

IBRAHIM J, Soman P
The past, present, and future of attenuation correction for myocardial perfusion imaging.
J Nucl Cardiol. 2023;30:1794-1796.
PubMed

CHOPRA S, Singh SS, Sood A, Parmar M, et al
Comparison of positional artifacts in myocardial perfusion imaging in supine and semi-reclining position using dedicated D-SPECT cardiac camera: validation using CT based attenuation correction.
J Nucl Cardiol. 2023;30:1782-1793.
PubMed Abstract available

SALEH JK, Barkmeier D, Frey KA, Davenport MS, et al
Diagnostic yield of whole-body (18)F-FDG PET/CT in patients with suspected cardiac sarcoidosis.
J Nucl Cardiol. 2023;30:1773-1781.
PubMed Abstract available

KUPUSOVIC J, Weber M, Bruns F, Kessler L, et al
PET/CT-identified atrial hypermetabolism is an index of atrial inflammation in patients with atrial fibrillation.
J Nucl Cardiol. 2023;30:1761-1772.
PubMed Abstract available

BERMAN DS
Making fair comparisons: The potency and necessity of combining myocardial perfusion imaging and CAC scanning.
J Nucl Cardiol. 2023;30:1751-1755.
PubMed

BERMAN DS
Making fair comparisons: The potency and necessity of combining myocardial perfusion imaging and CAC scanning.
J Nucl Cardiol. 2023;30:1751-1755.
PubMed

September 2023

JAHANDIDEH A, Virta J, Li XG, Liljenback H, et al
Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.
J Nucl Cardiol. 2023 Sep 27. doi: 10.1007/s12350-023-03371.
PubMed Abstract available

LIMA BB, Benz DC
Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET.
J Nucl Cardiol. 2023 Sep 20. doi: 10.1007/s12350-023-03376.
PubMed

HORGAN S, Sanghani R, Miller S, Al-Mallah M, et al
ASNC model coverage policy: 2023 cardiac positron emission tomography.
J Nucl Cardiol. 2023 Sep 5. doi: 10.1007/s12350-023-03355.
PubMed

August 2023

MIYATAKE M, Norikane T, Imajo M, Takami Y, et al
LV functional evaluation on (11)C-PiB PET/CT in cardiac amyloidosis.
J Nucl Cardiol. 2023;30:1693-1696.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum